Basic Trial Information
Trial Description
     Summary
     Further Trial Information
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

Trial Description

Summary

This randomized phase III clinical trial is studying chemotherapy with or without trastuzumab after surgery to see how well they work in treating women with invasive breast cancer. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) and giving chemotherapy after surgery may kill more tumor cells. Monoclonal antibodies, such as trastuzumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. It is not yet known whether combination chemotherapy is more effective with trastuzumab in treating breast cancer.

Further Study Information

PRIMARY OBJECTIVES:

I. To determine whether the addition of trastuzumab to chemotherapy (TC or AC→WP) improves invasive disease-free survival (IDFS) in women with resected node-positive or high-risk node-negative breast cancer which is reported as human epidermal growth factor receptor (HER)2-low by all HER2 testing performed.

SECONDARY OBJECTIVES:

I. To determine whether the addition of trastuzumab to chemotherapy (TC or AC→WP) improves disease-free survival (DFS)-ductal carcinoma in situ (DCIS) of women with resected node-positive or high-risk node-negative breast cancer which is reported as HER2-low by all HER2 testing performed.

II. To determine whether the addition of trastuzumab to chemotherapy (TC or AC→WP) improves breast cancer-free survival (BCFS) in women with resected node-positive or high-risk node-negative breast cancer which is reported as HER2-low by all HER2 testing performed.

III. To determine whether the addition of trastuzumab to chemotherapy (TC or AC→WP) improves recurrence-free interval (RFI) in women with resected node-positive or high-risk node-negative breast cancer which is reported as HER2-low by all HER2 testing performed.

IV. To determine whether the addition of trastuzumab to chemotherapy (TC or AC→WP) improves distant RFI in women with resected node-positive or high-risk node-negative breast cancer which is reported as HER2-low by all HER2 testing performed.

V. To determine whether the addition of trastuzumab to chemotherapy (TC or AC→WP) improves overall survival (OS) in women with resected node-positive or high-risk node-negative breast cancer which is reported as HER2-low by all HER2 testing performed.

VI. To evaluate the associations between amenorrhea and circulating reproductive hormone levels, and the associations between chemotherapy regimen, amenorrhea, and IDFS benefit in premenopausal women eligible at baseline for the menstrual history assessments.

VII. To evaluate the toxicity associated with each of the regimens. VIII. To test the hypothesis that the HER2 mRNA level is the predictor of the degree of benefit from trastuzumab and the threshold for benefit in the adjuvant setting is lower than defined by current ASCO/CAP Guidelines for HER2 assays (immunohistochemistry [IHC] and fluorescent in situ hybridization [FISH]).

IX. To identify and/or validate molecular predictors of the degree of benefit from the addition of trastuzumab to chemotherapy (TC or AC→WP).

X. To test the alternative hypothesis that the main determinant of trastuzumab response in the adjuvant setting of HER2-low breast cancer is through antibody-dependent cellular cytotoxicity (ADCC) by demonstrating that the polymorphism of the Fcγ receptor gene is predictive of the degree of benefit from the addition of trastuzumab to chemotherapy (TC or AC→WP).

XI. To examine the relationship between behavioral host factors (obesity, tobacco, alcohol) and comorbid conditions that may influence systemic inflammation and breast cancer outcomes, controlling for tumor/stage characteristics and treatment assignment.

XII. To examine the relationship between medication exposures that may influence systemic inflammation and breast cancer outcomes, controlling for tumor/stage characteristics and treatment assignment.

XIII. To examine the relationship between comorbid conditions, medication exposures, and behavioral host factors together and breast cancer outcomes, controlling for tumor/stage characteristics and treatment assignment.

OUTLINE: This is a multicenter study. Patients are stratified according to IHC score (1+ vs 2+), number of positive nodes (0-3 vs 4-9 vs 10+), hormone receptor status (estrogen [ER]-positive and/or progesterone receptor [PgR]-positive vs ER- and PgR-negative), and intended chemotherapy regimen* (docetaxel and cyclophosphamide vs doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel). Patients are randomized to 1 of 2 treatment arms.

NOTE: *Chemotherapy regimen is based on the investigator's preference.

ARM I:

GROUP A: Patients receive docetaxel intravenously (IV) over 60 minutes and cyclophosphamide IV over 30 minutes on day 1. Treatment repeats every 3 weeks for 6 courses.

GROUP B: Patients receive doxorubicin hydrochloride IV over 15 minutes and cyclophosphamide IV over 30 minutes on day 1.

Treatment repeats every 2 or 3 weeks (at the investigator's discretion) for 4 courses. Patients then receive paclitaxel IV over 60 minutes once weekly for 12 doses.

ARM II:

GROUP A: Patients receive chemotherapy as in arm IA. Patients also receive trastuzumab IV over 30-90 minutes on day 1. Trastuzumab treatment repeats every 3 weeks for 11 courses.

GROUP B: Patients receive chemotherapy as in arm IB. Patients also receive trastuzumab IV over 30-90 minutes weekly for 12 doses. After completion of paclitaxel, patients receive trastuzumab IV over 30-90 minutes on day 1.

Treatment repeats every 3 weeks for 13 courses. Tumor and blood samples may be collected periodically during study treatment for correlative studies.

After completion of study treatment, patients are followed up every 6 months for 5 years and then every 12 months for 5 years.

Eligibility Criteria

Inclusion Criteria:

• The tumor must be unilateral invasive adenocarcinoma of the breast on histologic examination

• All of the following staging criteria (according to the 7th edition of the American Joint Committee on Cancer [AJCC] Cancer Staging Manual) must be met:

• By pathologic evaluation, primary tumor must be pT1-3

• By pathologic evaluation, ipsilateral nodes must be pN0, pN1 (pN1mi, pN1a, pN1b,pN1c), pN2a, pN2b, pN3a, or pN3b

• If pN0, one of the following criteria must be met:

• pT2 and estrogen receptor (ER) negative and progesterone receptor (PgR) negative

• pT2 and ER positive (PgR status may be positive or negative) and either grade 3histology or Oncotype DX Recurrence Score of >= 25; or

• pT3 regardless of hormone receptor status, histologic grade, and Oncotype DX Recurrence Score

• No T4 tumors including inflammatory breast cancer

• No definitive clinical or radiologic evidence of metastatic disease

• NOTE: Chest imaging (mandatory for all patients) and other imaging (if required) must have been performed within 90 days prior to randomization

• No synchronous or previous contralateral invasive breast cancer (patients with synchronous and/or previous contralateral DCIS or lobular carcinoma in situ [LCIS] are eligible)

• No previous ipsilateral invasive breast cancer or ipsilateral DCIS (patients with synchronous or previous ipsilateral LCIS are eligible)

• HER2 status of the primary tumor must be evaluated prior to randomization; all testing performed must indicate that the tumor is HER2-low as defined below

• IHC must be performed and the IHC staining results must indicate a score of 1+ (in situ hybridization [ISH] testing is not required) or 2+ (ISH must also be performed and must indicate that the tumor is HER2-low as described below)

• If ISH testing is performed, test results must be as follows and IHC must be 1+ or 2+: The ratio of HER2 to CEP17 must be < 2.0 or, if a ratio was not performed, the HER2 gene copy number must be < 4 per nucleus

• Note: If the IHC staining intensity is reported as a range, e.g., 0 to 1+ or 1+ to 2+, the higher intensity score in the range should be used to determine eligibility

• No primary tumor with any of the following HER2 testing results:

• IHC staining intensity:

• 0 on all evaluations of specimens

• 3+ on evaluation of any specimen

• ISH with a ratio of HER2 to CEP17 >= 2.0 on evaluation of any specimen

• ISH result indicating HER2 gene copy number >= 4 per nucleus on evaluation of any specimen

• The patient must have undergone either a total mastectomy or breast-conserving surgery (lumpectomy) (patients who have had a nipple-sparing mastectomy are eligible)

• For patients who undergo lumpectomy, the margins of the resected specimen must be histologically free of invasive tumor and DCIS as determined by the local pathologist; if pathologic examination demonstrates tumor at the line of resection, additional operative procedures may be performed to obtain clear margins; if tumor is still present at the resected margin after re-excision(s), the patient must undergo total mastectomy to be eligible (patients with margins positive for LCIS are eligible without additional resection)

• For patients who undergo mastectomy, margins must be free of gross residual tumor(patients with microscopic positive margins are eligible as long as post-mastectomy RT of the chest wall will be administered)

• The interval between the last surgery for breast cancer (treatment or staging) and randomization must be no more than 84 days

• The patient must have completed one of the procedures for evaluation of pathologic nodal status listed below:

• Sentinel lymphadenectomy alone:

• If pathologic nodal staging based on sentinel lymphadenectomy is pN0 or pN1b

• If pathologic nodal staging based on sentinel lymphadenectomy is pN1mi or pN1a, the primary tumor must be T1 or T2 by pathologic evaluation and the nodal involvement must be limited to 1 or 2 positive nodes

• Sentinel lymphadenectomy followed by removal of additional non-sentinel lymph nodes if the sentinel node (SN) is positive

• Axillary lymphadenectomy with or without SN isolation procedures

• The patient must have ER analysis performed on the primary tumor prior to randomization; if ER analysis is negative, then PgR analysis must also be performed (either the core biopsy or surgical resection specimen can be used for ER/PgR testing); patients with a primary tumor that is hormone receptor-positive or receptor-negative are eligible

• Pre- or postmenopausal

• Eastern Cooperation Oncology Group (ECOG) performance status of 0 or 1

• Absolute neutrophil count (ANC) must be >= 1,200/mm^3

• Platelet count must be >= 100,000/mm^3

• Hemoglobin must be >= 10 g/dL

• Total bilirubin must be =< upper limit of normal (ULN) for the lab unless the patient has a bilirubin elevation > ULN to 1.5 x ULN due to Gilbert disease or similar syndrome involving slow conjugation of bilirubin

• Alkaline phosphatase must be =< 2.5 x ULN for the lab

• Aspartate aminotransferase (AST) must be =< 1.5 x ULN for the lab (if alanine aminotransferase [ALT] is performed instead of AST [per institution's standard practice], the ALT value must be =< 1.5 x ULN; if both were performed, the AST must be =< 1.5 x ULN)

• Alkaline phosphatase and AST may not both be > the ULN

• Patients with AST or alkaline phosphatase > ULN are eligible for inclusion in the study if liver imaging (CT, MRI, PET-CT, or PET scan) performed within 90 days prior to randomization does not demonstrate metastatic disease and the above requirements are met

• Patients with alkaline phosphatase that is > ULN but =< 2.5 x ULN or unexplained bone pain are eligible for inclusion in the study if a bone scan, positron emission tomography (PET)-computed tomography (CT) scan, or PET scan performed within 90 days prior to randomization does not demonstrate metastatic disease

• The most recent post operative serum creatinine performed within 6 weeks prior to randomization must be =< ULN for the lab

• Not pregnant or nursing

• Negative pregnancy test

• Left ventricular ejection fraction (LVEF) assessment must be performed within 90 days prior to randomization; LVEF assessment performed by 2-dimensional (D) echo cardiogram is preferred, however, multi-gated acquisition (MUGA) scan maybe substituted based on institutional preferences

• For patients who will receive the TC chemotherapy regimen, the LVEF must be >= 50% regardless of the cardiac-imaging facility's lower limit of normal

• For patients who will receive the AC→WP chemotherapy regimen, the LVEF must be >= 55% regardless of the cardiac-imaging facility's lower limit of normal

• NOTE: Since the pre-entry LVEF serves as the baseline for comparing subsequent LVEF assessments, it is critical that this baseline study be an accurate assessment. If the baseline LVEF is > 70%, the investigator is encouraged to have the accuracy of the initial LVEF result confirmed and repeat the test if the accuracy is uncertain

• No history of non-breast malignancies (except for in situ cancers treated only by local excision and basal cell and squamous cell carcinomas of the skin) within 5 years prior to randomization

• No cardiac disease (history of and/or active disease) that would preclude the use of the drugs included in the treatment regimens, including, but not limited to:

• Active cardiac disease:

• Angina pectoris that requires the current use of anti-anginal medication

• Ventricular arrhythmias except for benign premature ventricular contractions

• Supraventricular and nodal arrhythmias requiring a pacemaker or not controlled with medication

• Conduction abnormality requiring a pacemaker

• Valvular disease with documented compromise in cardiac function

• Symptomatic pericarditis

• History of cardiac disease:

• Myocardial infarction documented by elevated cardiac enzymes or persistent regional wall abnormalities on assessment of left ventricle (LV) function

• History of documented congestive heart failure (CHF)

• Documented cardiomyopathy

• No hypertension defined according to the following ineligibility criteria:

• For patients who will receive TC (regardless of the patient's age): uncontrolled hypertension defined as sustained systolic blood pressure (BP) > 150 mm Hg or diastolic BP > 90 mm Hg (patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria)

• For patients < 50 years old who will receive AC→WP: uncontrolled hypertension defined as sustained systolic BP > 150 mm Hg or diastolic BP > 90 mm Hg (patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria)

• For patients >= 50 years old who will receive AC→WP: uncontrolled hypertension defined as sustained systolic BP > 150 mm Hg or diastolic BP > 90 mm Hg OR controlled hypertension (systolic BP =< 150 mm Hg and diastolic BP =< 90 mmHg), if anti-hypertensive medication(s) are needed

• NOTE: Patients who are not eligible based on the AC→WP regimen BP criteria but who meet the TC regimen BP criteria are eligible for B-47 if the intended chemotherapy regimen is changed to TC

• No active hepatitis B or hepatitis C with abnormal liver function tests

• No intrinsic lung disease resulting in dyspnea

• No poorly controlled diabetes mellitus

• No active infection or chronic infection requiring chronic suppressive antibiotics

• No nervous system disorder (paresthesia, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade 2, per the Common Terminology Criteria for Adverse Events (CTCAE) v4.0

• No conditions that would prohibit administration of corticosteroids

• No known hypersensitivity to any of the study drugs or excipients, e.g., polysorbate 80 and Cremophor EL

• No other non-malignant systemic disease that would preclude the patient from receiving study treatment or would prevent required follow-up

• No psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements

• Concurrent participation in NSABP-B-39 allowed

• No previous therapy with anthracyclines, taxanes, or trastuzumab for any malignancy

• No chemotherapy or HER2-targeted therapy administered for the currently diagnosed breast cancer prior to randomization

• No whole-breast radiation therapy (RT) prior to randomization or partial-breast RT that cannot be completed on or before the date of randomization

• No use of any investigational product within 30 days prior to randomization

• No continued endocrine therapy such as raloxifene or tamoxifen (or other SERM) or an aromatase inhibitor (patients are eligible if these medications are discontinued prior to randomization)

• No continued use of sex hormonal therapy, e.g., birth control pills, ovarian hormone replacement therapy (patients are eligible if these medications are discontinued prior to randomization)

• No chronic daily treatment with corticosteroids with a dose of >= 10 mg/day methylprednisol one equivalent (excluding inhaled steroids)

• No other concurrent chemotherapy

• No other concurrent targeted therapy for malignancy

• No partial-breast irradiation following randomization

Trial Contact Information

Trial Lead Organizations/Sponsors

National Cancer Institute

Louis Fehrenbacher

Principal Investigator

U.S.A.
Alabama
	Anniston
	Regional Medical Center
		Ellen N. Spremulli	Ph: 256-235-5084
			Email: wwatson@rmccares.org
		Ellen N. Spremulli	Principal Investigator
Alaska
	Anchorage
	Providence Cancer Center
		Jeanne E. Anderson	Ph: 907-261-3109
		Jeanne E. Anderson	Principal Investigator
	Fairbanks
	Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
		Craig R. Nichols	Ph: 503-215-6412
		Craig R. Nichols	Principal Investigator
Arizona
	Phoenix
	Arizona Oncology Associates-Biltmore Cancer Center
		Tania E. Cortas	Ph: 602-277-4868
		Tania E. Cortas	Principal Investigator
	Scottsdale
	Premiere Oncology of Arizona
		Giraldo (Gerry) Kato	Ph: 480-860-5000
		Giraldo (Gerry) Kato	Principal Investigator
California
	Anaheim
	Kaiser Permanente Medical Center - Anaheim/Orange County
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Antioch
	Kaiser Permanente-Deer Valley Medical Center
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Baldwin Park
	Kaiser Permanente Medical Center - Baldwin Park
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Bellflower
	Kaiser Permanente Medical Center - Bellflower
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Berkeley
	Alta Bates Summit Comprehensive Cancer Center
		David H. Irwin	Ph: 510-204-3428
		David H. Irwin	Principal Investigator
	Burbank
	Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
		Raul R. Mena	Ph: 818-847-3220
		Raul R. Mena	Principal Investigator
		Raul R. Mena	Ph: 818-847-3220
		Raul R. Mena	Principal Investigator
	Burlingame
	Peninsula Medical Center
		David H. Irwin	Ph: 510-204-3428
		David H. Irwin	Principal Investigator
	Castro Valley
	East Bay Radiation Oncology Center
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	Concord
	John Muir Medical Center-Concord Campus
		Elizabeth A. Odumakinde	Ph: 925-674-2580
		Elizabeth A. Odumakinde	Principal Investigator
	Fairfield
	North Bay Cancer Center
		Brian G. Vikstrom	Ph: 707-646-4016
		Brian G. Vikstrom	Principal Investigator
	Fontana
	Kaiser Permanente Medical Center - Fontana
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Fremont
	Kaiser Permanente - Fremont
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Fresno
	Kaiser Permanente Fresno Medical Center
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Glendale
	Glendale Adventist Medical Center
		Ghassan Al-Jazayrly	Ph: 818-409-7653
		Ghassan Al-Jazayrly	Principal Investigator
	Greenbrae
	Marin Cancer Care Inc
		Peter D. Eisenberg	Ph: 415-925-5000
			Email: info@marinspecialtycare.com
		Peter D. Eisenberg	Principal Investigator
	Sutter Health Western Division Cancer Research Group
		David H. Irwin	Ph: 510-204-3428
		David H. Irwin	Principal Investigator
	Harbor City
	Kaiser Permanente Medical Center - Harbor City
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Hayward
	Kaiser Permanente Medical Center - Hayward
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Irvine
	Southern California Permamente Medical Group
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Long Beach
	Todd Cancer Institute at Long Beach Memorial Medical Center
		Bichlien Nguyen	Ph: 562-933-0900
		Bichlien Nguyen	Principal Investigator
	Los Angeles
	Kaiser Foundation Hospital - West Los Angeles
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Kaiser Permanente Medical Center - Los Angeles
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Martinez
	Contra Costa Regional Medical Center
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	Modesto
	Kaiser Permanente-Modesto
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Monterey
	Community Hospital of the Monterey Peninsula Comprehensive Cancer Center
		John Hausdorff	Ph: 831-625-4753
		John Hausdorff	Principal Investigator
	Mountain View
	El Camino Hospital Cancer Center
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	Palo Alto Medical Foundation
		Peter P. Yu	Ph: 650-934-7000
		Peter P. Yu	Principal Investigator
	Oakland
	Alta Bates Summit Medical Center - Summit Campus
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	Bay Area Breast Surgeons, Incorporated
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	CCOP - Bay Area Tumor Institute
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	Epic Care - Oakland
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	Highland General Hospital
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	Kaiser Permanente Medical Center - Oakland
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Larry G Strieff MD Medical Corporation
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	Orange
	St. Joseph Hospital Regional Cancer Center - Orange
		Chau "Cindy" N. Tran	Ph: 714-734-6220
		Chau "Cindy" N. Tran	Principal Investigator
	Palm Springs
	Desert Regional Medical Center Comprehensive Cancer Center
		Scott D. Brook	Ph: 760-416-4730
		Scott D. Brook	Principal Investigator
	Palo Alto
	Palo Alto Medical Foundation
		David S. Leibowitz	Ph: 650-853-2906
			Email: waldorj@pamf.org
		David S. Leibowitz	Principal Investigator
	Panorama City
	Kaiser Permanente Medical Group
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Pismo Beach
	Palchak David MD
		David L. Palchak	Ph: 805-474-9143
		David L. Palchak	Principal Investigator
	Rancho Mirage
	Lucy Curci Cancer Center at Eisenhower Memorial Hospital and Medical Center
		Luke P. Dreisbach	Ph: 760-834-3798
		Luke P. Dreisbach	Principal Investigator
	Redwood City
	Kaiser Permanente Medical Center - Redwood City
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Richmond
	Kaiser Permanente Medical Center - Richmond
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Riverside
	Kaiser Permanente Medical Center - Riverside
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	Roseville
	Kaiser Permanente Medical Center - Roseville
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Sutter Cancer Center at Roseville Medical Center
		Nitin Rohatgi	Ph: 916-454-6500
			Email: cancerinfo@sutterhealth.org
		Nitin Rohatgi	Principal Investigator
	Sacramento
	Kaiser Permanente Medical Center - Sacramento
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	South Sacramento Kaiser-Permanente Medical Center
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Sutter General Hospital
		Nitin Rohatgi	Ph: 916-454-6500
			Email: cancerinfo@sutterhealth.org
		Nitin Rohatgi	Principal Investigator
	Saint Helena
	Saint Helena Hospital
		Gregory B. Smith	Ph: 707-967-3698
		Gregory B. Smith	Principal Investigator
	Salinas
	Salinas Valley Memorial
		Laura V. Stampleman	Ph: 831-759-3271
			Email: nvoogd@svmh.com
		Laura V. Stampleman	Principal Investigator
	San Diego
	Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	San Francisco
	California Pacific Medical Center - California Campus
		David H. Irwin	Ph: 510-204-3428
		David H. Irwin	Principal Investigator
	Kaiser Permanente Medical Center - San Francisco Geary Campus
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	San Jose
	Kaiser Permanente Medical Center - Santa Teresa
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	San Marcos
	Kaiser Permanente Health Care
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
	San Pablo
	Doctors Medical Center - San Pablo Campus
		James H. Feusner	Ph: 510-450-7600
		James H. Feusner	Principal Investigator
	San Rafael
	Kaiser Foundation Hospital - San Rafael
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Santa Clara
	Kaiser Permanente Medical Center - Santa Clara Kiely Campus
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Santa Rosa
	Kaiser Permanente Medical Center - Santa Rosa
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Sutter Pacific Medical Foundation
		David H. Irwin	Ph: 510-204-3428
		David H. Irwin	Principal Investigator
	South San Francisco
	Kaiser Permanente Medical Center - South San Francisco
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Stanford
	Stanford Cancer Center
		Irene L. Wapnir	Ph: 650-498-7061
			Email: clinicaltrials@med.stanford.edu
		Irene L. Wapnir	Principal Investigator
	Stockton
	Kaiser Permanente Medical Facility - Stockton
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Vacaville
	Kaiser Permanente Medical Center-Vacaville
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Vallejo
	Kaiser Permanente Medical Center - Vallejo
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Solano Clinical Research
		David H. Irwin	Ph: 510-204-3428
		David H. Irwin	Principal Investigator
	Walnut Creek
	John Muir Medical Center
		Elizabeth A. Odumakinde	Ph: 925-674-2580
		Elizabeth A. Odumakinde	Principal Investigator
	Kaiser Permanente Medical Center - Walnut Creek
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Woodland Hills
	Kaiser Permanente Medical Cener - Woodland Hills
		Jonathan A. Polikoff	Ph: 626-564-3455
		Jonathan A. Polikoff	Principal Investigator
Colorado
	Aurora
	Medical Center of Aurora - South Campus
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Boulder
	Boulder Community Hospital
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Colorado Springs
	Memorial Hospital Cancer Center - Colorado Springs
		Dax Kurbegov	Ph: 719-365-2406
		Dax Kurbegov	Principal Investigator
	Penrose Cancer Center at Penrose Hospital
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Denver
	CCOP - Colorado Cancer Research Program
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Kaiser Permanente-Franklin
		Alexander Menter	Ph: 303-614-1300
		Alexander Menter	Principal Investigator
	Porter Adventist Hospital
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Presbyterian - St. Luke's Medical Center
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Rose Medical Center
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	St. Anthony Central Hospital
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	St. Joseph Hospital
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Englewood
	Swedish Medical Center
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Fort Collins
	Front Range Cancer Specialists
		Diana C. Medgyesy	Ph: 970-212-7600
		Diana C. Medgyesy	Principal Investigator
	Poudre Valley Hospital
		Paolo Romero	Ph: 970-495-8226
		Paolo Romero	Principal Investigator
	Greeley
	North Colorado Medical Center
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Lafayette
	Kaiser Permanente-Rock Creek
		Alexander Menter	Ph: 303-614-1300
		Alexander Menter	Principal Investigator
	Littleton
	Littleton Adventist Hospital
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Lone Tree
	Sky Ridge Medical Center
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Longmont
	Hope Cancer Care Center at Longmont United Hospital
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Loveland
	McKee Medical Center
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Parker
	Parker Adventist Hospital
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Pueblo
	St. Mary - Corwin Regional Medical Center
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
	Wheat Ridge
	Exempla Lutheran Medical Center
		Eduardo R. Pajon	Ph: 888-785-6789
		Eduardo R. Pajon	Principal Investigator
Connecticut
	Hartford
	Helen and Harry Gray Cancer Center at Hartford Hospital
		Patricia A. DeFusco	Ph: 860-545-5363
		Patricia A. DeFusco	Principal Investigator
	Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Meriden
	MidState Medical Center
		Patricia A. DeFusco	Ph: 860-545-5363
		Patricia A. DeFusco	Principal Investigator
	New Britain
	George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
		Brian J. Byrne	Ph: 860-224-5660
		Brian J. Byrne	Principal Investigator
	Norwich
	Eastern Connecticut Hematology and Oncology Associates
		Anca M. Bulgaru	Ph: 860-886-8362
		Anca M. Bulgaru	Principal Investigator
Delaware
	Lewes
	Tunnell Cancer Center at Beebe Medical Center
		David D. Biggs	Ph: 302-733-6227
		David D. Biggs	Principal Investigator
	Newark
	Helen F. Graham Cancer Center at Christiana Hospital
		David D. Biggs	Ph: 302-733-6227
		David D. Biggs	Principal Investigator
District of Columbia
	Washington
	Kaiser Permanente-Capitol Hill Medical Center
		Leon C. Hwang	Ph: 301-816-7446
		Leon C. Hwang	Principal Investigator
	Sibley Memorial Hospital
		Antonio C. Wolff	Ph: 410-955-8804
			Email: jhcccro@jhmi.edu
		Antonio C. Wolff	Principal Investigator
Florida
	Daytona Beach
	Halifax Health Medical Center-Centers for Oncology
		Ruby Anne E. Deveras	Ph: 386-254-4211
		Ruby Anne E. Deveras	Principal Investigator
	Fort Lauderdale
	Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
		Michael A. Schwartz	Ph: 305-674-2625
			Email: info@msccop.com
		Michael A. Schwartz	Principal Investigator
	Jacksonville
	Baptist Cancer Institute - Jacksonville
		Troy H. Guthrie	Ph: 904-202-7051
		Troy H. Guthrie	Principal Investigator
	Saint Vincent's Medical Center
		Joel A. Stone	Ph: 904-538-3667
		Joel A. Stone	Principal Investigator
	Jupiter
	Ella Milbank Foshay Cancer Center at Jupiter Medical Center
		Michael A. Schwartz	Ph: 305-674-2625
			Email: info@msccop.com
		Michael A. Schwartz	Principal Investigator
	Lakeland
	Center for Cancer Care and Research at Watson Clinic, LLP
		Shalini Mulaparthi	Ph: 863-680-7780
		Shalini Mulaparthi	Principal Investigator
	Miami Beach
	CCOP - Mount Sinai Medical Center
		Michael A. Schwartz	Ph: 305-674-2625
			Email: info@msccop.com
		Michael Schwartz	Principal Investigator
	Ocala
	Ocala Oncology Center
		Craig H. Reynolds	Ph: 412-330-4624
			Email: Mary.ketner@nsabp.org
		Craig H. Reynolds	Principal Investigator
	Orlando
	Florida Hospital Cancer Institute at Florida Hospital Orlando
		Carlos A. Alemany	Ph: 407-303-5623
		Carlos A. Alemany	Principal Investigator
	M.D. Anderson Cancer Center at Orlando
		Nikita C. Shah	Ph: 321-841-7246
		Nikita C. Shah	Principal Investigator
	Sarasota
	Florida Cancer Specialists - Sarasota Downtown
		Janice F. Eakle	Ph: 941-917-2225
		Janice F. Eakle	Principal Investigator
Georgia
	Albany
	Phoebe Cancer Center at Phoebe Putney Memorial Hospital
		Jose M. Tongol	Ph: 229-312-2251
		Jose M. Tongol	Principal Investigator
	Athens
	Northeast Georgia Cancer Care, LLC - Medical Oncology
		Anand P. Jillella	Ph: 706-721-1663
			Email: cancer@georgiahealth.edu
		Anand P. Jillella	Principal Investigator
	Atlanta
	CCOP - Atlanta Regional
		Thomas E. Seay	Ph: 678-843-7119
			Email: kpackard@sjha.org
		Thomas E. Seay	Principal Investigator
	Grady Health System
		Ruth M. O'Regan	Ph: 404-778-1868
		Ruth M. O'Regan	Principal Investigator
	Northside Hospital Cancer Center
		Thomas E. Seay	Ph: 678-843-7119
			Email: kpackard@sjha.org
		Thomas E. Seay	Principal Investigator
	Piedmont Hospital
		Thomas E. Seay	Ph: 678-843-7119
			Email: kpackard@sjha.org
		Thomas E. Seay	Principal Investigator
	Saint Joseph's Hospital of Atlanta
		Thomas E. Seay	Ph: 678-843-7119
			Email: kpackard@sjha.org
		Thomas E. Seay	Principal Investigator
	Winship Cancer Institute of Emory University
		Ruth M. O'Regan	Ph: 404-778-1868
		Ruth M. O'Regan	Principal Investigator
		Ruth M. O'Regan	Ph: 404-778-1868
		Ruth M. O'Regan	Principal Investigator
	Augusta
	Medical College of Georgia Cancer Center
		Anand P. Jillella	Ph: 706-721-1663
			Email: cancer@georgiahealth.edu
		Anand P. Jillella	Principal Investigator
	Columbus
	John B. Amos Cancer Center
		Thomas E. Seay	Ph: 678-843-7119
			Email: kpackard@sjha.org
		Thomas E. Seay	Principal Investigator
	Decatur
	Charles B. Eberhart Cancer Center at DeKalb Medical Center
		Jayanthi Srinivasiah	Ph: 404-501-3279
		Jayanthi Srinivasiah	Principal Investigator
	Dublin
	Dublin Hematology Oncology Care PC
		Anand P. Jillella	Ph: 706-721-1663
			Email: cancer@georgiahealth.edu
		Anand P. Jillella	Principal Investigator
	Fayetteville
	Piedmont Fayette Hospital
		Thomas E. Seay	Ph: 678-843-7119
			Email: kpackard@sjha.org
		Thomas E. Seay	Principal Investigator
	Lawrenceville
	Gwinnett Medical Center
		Thomas E. Seay	Ph: 678-843-7119
			Email: kpackard@sjha.org
		Thomas E. Seay	Principal Investigator
	Macon
	Medical Center of Central Georgia
		Frederick M. Schnell	Ph: 478-633-1226
		Frederick M. Schnell	Principal Investigator
	Riverdale
	Southern Regional Medical Center
		Thomas E. Seay	Ph: 404-303-3355
		Thomas E. Seay	Principal Investigator
	Rome
	Harbin Clinic Cancer Center - Medical Oncology
		Thomas E. Seay	Ph: 678-843-7119
			Email: kpackard@sjha.org
		Thomas E. Seay	Principal Investigator
	Savannah
	Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
		Harvey C. Lebos	Ph: 912-350-8568
		Harvey C. Lebos	Principal Investigator
	Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler
		Mark A. Taylor	Ph: 912-350-8568
		Mark A. Taylor	Principal Investigator
Hawaii
	Aiea
	Kapiolani Medical Center at Pali Momi
		Kenneth N. Sumida	Ph: 808-586-2979
			Email: dorothy@crch.hawaii.edu
		Kenneth N. Sumida	Principal Investigator
	Honolulu
	Cancer Research Center of Hawaii
		Kenneth N. Sumida	Ph: 808-586-2979
			Email: dorothy@crch.hawaii.edu
		Kenneth N. Sumida	Principal Investigator
	Hawaii Medical Center - East
		Kenneth N. Sumida	Ph: 808-586-2979
			Email: dorothy@crch.hawaii.edu
		Kenneth N. Sumida	Principal Investigator
	Kaiser Permanente - Moanalua Medical Center and Clinic
		Louis Fehrenbacher	Ph: 626-564-3455
		Louis Fehrenbacher	Principal Investigator
	Kapiolani Medical Center for Women and Children
		Kenneth N. Sumida	Ph: 808-586-2979
			Email: dorothy@crch.hawaii.edu
		Kenneth N. Sumida	Principal Investigator
	OnCare Hawaii, Incorporated - Kuakini
		Kenneth N. Sumida	Ph: 808-586-2979
			Email: dorothy@crch.hawaii.edu
		Kenneth N. Sumida	Principal Investigator
	OnCare Hawaii, Incorporated - Lusitana
		Kenneth N. Sumida	Ph: 808-586-2979
			Email: dorothy@crch.hawaii.edu
		Kenneth N. Sumida	Principal Investigator
	Queen's Cancer Institute at Queen's Medical Center
		Kenneth N. Sumida	Ph: 808-586-2979
			Email: dorothy@crch.hawaii.edu
		Kenneth N. Sumida	Principal Investigator
	Straub Clinic and Hospital, Incorporated
		Kenneth N. Sumida	Ph: 808-586-2979
			Email: dorothy@crch.hawaii.edu
		Kenneth N. Sumida	Principal Investigator
	Lihue
	Wilcox Memorial Hospital and Kauai Medical Clinic
		Kenneth N. Sumida	Ph: 808-586-2979
			Email: dorothy@crch.hawaii.edu
		Kenneth N. Sumida	Principal Investigator
Idaho
	Boise
	Mountain States Tumor Institute at St. Luke's Regional Medical Center
		Paul G. Montgomery	Ph: 800-845-4624
		Paul G. Montgomery	Principal Investigator
	Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Fruitland
	Saint Luke's Mountain States Tumor Institute - Fruitland
		Paul G. Montgomery	Ph: 800-845-4624
		Paul G. Montgomery	Principal Investigator
	Meridian
	Mountain States Tumor Institute - Meridian
		Paul G. Montgomery	Ph: 800-845-4624
		Paul G. Montgomery	Principal Investigator
	Nampa
	Saint Luke's Mountain States Tumor Institute
		Paul G. Montgomery	Ph: 800-845-4624
		Paul G. Montgomery	Principal Investigator
	Twin Falls
	Saint Luke's Mountain States Tumor Institute-Twin Falls
		Paul G. Montgomery	Ph: 800-845-4624
		Paul G. Montgomery	Principal Investigator
Illinois
	Bloomington
	St. Joseph Medical Center
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Bloomington%
	Illinois CancerCare - Bloomington
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Canton
	Illinois CancerCare - Canton
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Carthage
	Illinois CancerCare - Carthage
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Chicago
	John H. Stroger, Jr. Hospital of Cook County
		Thomas E. Lad	Ph: 312-864-6000
		Thomas E. Lad	Principal Investigator
	Louis A. Weiss Memorial Hospital
		Keith L. Shulman	Ph: 773-564-5044
		Keith L. Shulman	Principal Investigator
	Resurrection Medical Center
		Christopher G. Rose	Ph: 773-792-5116
		Christopher G. Rose	Principal Investigator
	Rush Cancer Institute at Rush University Medical Center
		Melody A. Cobleigh	Ph: 312-942-5498
			Email: clinical_trials@rush.edu
		Melody A. Cobleigh	Principal Investigator
	University of Illinois Cancer Center
		Lucy F. Chen	Ph: 312-355-3046
		Lucy F. Chen	Principal Investigator
	Decatur
	Decatur Memorial Hospital Cancer Care Institute
		James L. Wade	Ph: 217-876-4740
			Email: kcheek@dmhhs.org
		James L. Wade	Principal Investigator
	Elgin
	Sherman Hospital
		James L. Wade	Ph: 217-876-4740
			Email: kcheek@dmhhs.org
		James L. Wade	Principal Investigator
	Elmhurst
	Elmhurst Memorial Hospital
		Lucio Di Nunno	Ph: 630-782-7900
		Lucio Di Nunno	Principal Investigator
	Eureka
	Illinois CancerCare - Eureka
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Galesburg
	Galesburg Clinic, PC
		Nguyet A. Le-Lindqwister	Ph: 800-793-2262
		Nguyet A. Le-Lindqwister	Principal Investigator
	Geneva
	Delnor Community Hospital
		Perry J. Menini	Ph: 630-232-0610
		Perry J. Menini	Principal Investigator
	Harvey
	Ingalls Cancer Care Center at Ingalls Memorial Hospital
		Mark F. Kozloff	Ph: 708-915-4673
			Email: clinicaltrials@ingalls.org
		Mark F. Kozloff	Principal Investigator
	Joliet
	Joliet Oncology-Hematology Associates, Limited - West
		Kulumani M. Sivarajan	Ph: 815-730-3098
			Email: maureenc@jolietoncology.com
		Kulumani M. Sivarajan	Principal Investigator
	Kankakee
	Provena St. Mary's Regional Cancer Center - Kankakee
		Riaz Elahi	Ph: 888-823-5923
			Email: ctsucontact@westat.com
		Riaz Elahi	Principal Investigator
	Kewanee
	Illinois CancerCare - Kewanee Clinic
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Macomb
	Illinois CancerCare - Macomb
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Maywood
	Cardinal Bernardin Cancer Center at Loyola University Medical Center
		Kathy S. Albain	Ph: 708-226-4357
		Kathy S. Albain	Principal Investigator
	Monmouth
	Illinois CancerCare - Monmouth
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	OSF Holy Family Medical Center
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Mt. Vernon
	Good Samaritan Regional Health Center
		Bethany G. Sleckman	Ph: 913-948-5588
		Bethany G. Sleckman	Principal Investigator
	Naperville
	Edward Hospital/Cancer Center
		Joseph J. Kash	Ph: 630-646-6075
		Joseph J. Kash	Principal Investigator
	Normal
	Community Cancer Center
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Ottawa
	Community Hospital of Ottawa
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Illinois CancerCare - Ottawa
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Pekin
	Cancer Treatment Center at Pekin Hospital
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Illinois CancerCare - Pekin
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Peoria
	CCOP - Illinois Oncology Research Association
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Illinois CancerCare - Peoria
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Methodist Medical Center of Illinois
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	OSF St. Francis Medical Center
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Proctor Hospital
		Nguyet A. Le-Lindqwister	Ph: 800-793-2262
		Nguyet A. Le-Lindqwister	Principal Investigator
	Peru
	Illinois CancerCare - Peru
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Illinois Valley Community Hospital
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	Princeton
	Illinois CancerCare - Princeton
		John W. Kugler	Ph: 800-793-2262
		John W. Kugler	Principal Investigator
	River Forest
	West Suburban Center for Cancer Care
		Isoken Koko	Ph: 708-488-0882
		Isoken Koko	Principal Investigator
	Rockford
	Swedish-American Regional Cancer Center
		Harvey E. Einhorn	Ph: 815-489-4413
		Harvey Eric Einhorn	Principal Investigator
	Springfield
	Regional Cancer Center at Memorial Medical Center
		James L. Wade	Ph: 217-876-4740
			Email: kcheek@dmhhs.org
		James L. Wade	Principal Investigator
	Warrenville
	Central Dupage Cancer Center
		John D. Ayers	Ph: 630-352-5300
		John D. Ayers	Principal Investigator
Indiana
	Anderson
	Saint John's Health System Cancer Center
		Hazim I. Rimawi	Ph: 765-751-5850
			Email: alpatterson@medicalconsultantspc.com
		Hazim I. Rimawi	Principal Investigator
	Elkhart
	Elkhart Clinic, LLC
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Elkhart General Hospital
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Michiana Hematology-Oncology, PC - Elkhart
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Fort Wayne
	Fort Wayne Medical Oncology and Hematology
		Sreenivasa R. Nattam	Ph: 260-484-8830
			Email: ledgar@fwmoh.com
		Sreenivasa Rao Nattam	Principal Investigator
	Indianapolis
	Community Regional Cancer Care at Community Hospital East
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Community Regional Cancer Care at Community Hospital North
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Franciscan St. Francis Health
		Howard M. Gross	Ph: 765-983-3000
		Howard M. Gross	Principal Investigator
	Kokomo
	Community Howard Regional Health
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	La Porte
	Indiana University Health La Porte Hospital
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Mishawaka
	Michiana Hematology Oncology PC-Mishawaka
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Saint Joseph Regional Medical Center-Mishawaka
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Muncie
	IU Health Ball Memorial Hospital
		Dejuania A. Brown	Ph: 765-751-5850
			Email: alpatterson@medicalconsultantspc.com
		Dejuania A. Brown	Principal Investigator
	Munster
	Community Hospital
		Erwin L. Robin	Ph: 708-915-6747
		Erwin L. Robin	Principal Investigator
	Plymouth
	Michiana Hematology Oncology PC-Plymouth
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Richmond
	Reid Hospital & Health Care Services
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	South Bend
	CCOP - Northern Indiana CR Consortium
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Memorial Hospital of South Bend
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Michiana Hematology-Oncology, PC - South Bend
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Westville
	Michiana Hematology Oncology-PC Westville
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
Iowa
	Ames
	McFarland Clinic, PC
		Joseph J. Merchant	Ph: 515-239-2621
		Joseph J. Merchant	Principal Investigator
	Cedar Rapids
	Cedar Rapids Oncology Associates
		Deborah W. Wilbur	Ph: 319-363-2690
		Deborah W. Wilbur	Principal Investigator
		Deborah W. Wilbur	Ph: 319-363-2690
		Deborah W. Wilbur	Principal Investigator
	Iowa Blood and Cancer Care
		David W. Zenk	Ph: 319-297-2900
			Email: cetscheidt@pcofiowa.com
		David W. Zenk	Principal Investigator
	Mercy Regional Cancer Center at Mercy Medical Center
		David W. Zenk	Ph: 319-297-2900
			Email: cetscheidt@pcofiowa.com
		David W. Zenk	Principal Investigator
	St. Luke's Hospital
		David W. Zenk	Ph: 319-297-2900
			Email: cetscheidt@pcofiowa.com
		David W. Zenk	Principal Investigator
	Clive
	Medical Oncology and Hematology Associates - West Des Moines
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	Mercy Cancer Center-West Lakes
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	Davenport
	Genesis Regional Cancer Center at Genesis Medical Center
		George Kovach	Ph: 800-446-6088
			Email: werners@genesishealth.com
		George Kovach	Principal Investigator
	Des Moines
	CCOP - Iowa Oncology Research Association
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	John Stoddard Cancer Center at Iowa Lutheran Hospital
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	John Stoddard Cancer Center at Iowa Methodist Medical Center
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	Medical Oncology and Hematology Associates at John Stoddard Cancer Center
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	Medical Oncology and Hematology Associates at Mercy Cancer Center
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	Mercy Cancer Center at Mercy Medical Center - Des Moines
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	Iowa City
	Holden Comprehensive Cancer Center at University of Iowa
		Mark W. Karwal	Ph: 800-237-1225
		Mark W. Karwal	Principal Investigator
	Ottumwa
	McCreery Cancer Center at Ottumwa Regional
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	Sioux City
	Mercy Medical Center - Sioux City
		Donald B. Wender	Ph: 712-252-0088
		Donald B. Wender	Principal Investigator
	Siouxland Hematology-Oncology Associates, LLP
		Donald B. Wender	Ph: 712-252-0088
		Donald B. Wender	Principal Investigator
	St. Luke's Regional Medical Center
		Donald B. Wender	Ph: 712-252-0088
		Donald B. Wender	Principal Investigator
	West Des Moines
	Mercy Medical Center-West Lakes
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
	Methodist West Hospital
		Robert J. Behrens	Ph: 888-244-6061
			Email: sherrijr@iora.org
		Robert J. Behrens	Principal Investigator
Kansas
	Chanute
	Cancer Center of Kansas, PA - Chanute
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Dodge City
	Cancer Center of Kansas, PA - Dodge City
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	El Dorado
	Cancer Center of Kansas, PA - El Dorado
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Fort Scott
	Cancer Center of Kansas - Fort Scott
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Independence
	Cancer Center of Kansas-Independence
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Kingman
	Cancer Center of Kansas, PA - Kingman
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Lawrence
	Lawrence Memorial Hospital
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Liberal
	Cancer Center of Kansas-Liberal
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	McPherson
	Cancer Center of Kansas, PA - McPherson
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Newton
	Cancer Center of Kansas, PA - Newton
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Parsons
	Cancer Center of Kansas, PA - Parsons
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Prairie Village
	Kansas City CCOP
		Rakesh Gaur	Ph: 913-948-5588
			Email: amy.krushelniski@hcahealthcare.com
		Rakesh Gaur	Principal Investigator
	Pratt
	Cancer Center of Kansas, PA - Pratt
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Salina
	Cancer Center of Kansas, PA - Salina
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Wellington
	Cancer Center of Kansas, PA - Wellington
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Wichita
	Associates in Womens Health, PA - North Review
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Cancer Center of Kansas, PA - Medical Arts Tower
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Cancer Center of Kansas, PA - Wichita
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	CCOP - Wichita
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Via Christi Cancer Center at Via Christi Regional Medical Center
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
	Winfield
	Cancer Center of Kansas, PA - Winfield
		Shaker R. Dakhil	Ph: 316-262-4467
		Shaker R. Dakhil	Principal Investigator
Kentucky
	Lexington
	Central Baptist Hospital
		Peter S. Tate	Ph: 859-260-6425
		Peter S. Tate	Principal Investigator
	Lucille P. Markey Cancer Center at University of Kentucky
		Edward H. Romond	Ph: 859-257-3379
		Edward H. Romond	Principal Investigator
	Louisville
	Baptist Hospital East - Louisville
		Udaya G. Joseph	Ph: 502-897-8592
			Email: Cbcresearch@bhsi.com
		Udaya G. Joseph	Principal Investigator
	Norton Health Care Pavilion - Downtown
		Janell Seeger	Ph: 502-629-2500
		Janell Seeger	Principal Investigator
	The James Graham Brown Cancer Center at University of Louisville
		Elizabeth C. Riley	Ph: 866-530-5516
		Elizabeth C. Riley	Principal Investigator
	Owensboro
	Owensboro Mercy Medical Center
		James R. Thomas	Ph: 270-688-3691
			Email: shawns@omhs.org
		James R. Thomas	Principal Investigator
Louisiana
	Alexandria
	Christus Saint Frances Cabrini Hospital
		Ulla J. Ule	Ph: 504-988-6121
		Ulla J. Ule	Principal Investigator
	Baton Rouge
	Hematology and Oncology Clinic
		Bridgette M. Collins-Burow	Ph: 504-988-6121
		Bridgette M. Collins-Burow	Principal Investigator
	Mary Bird Perkins Cancer Center - Baton Rouge
		Robert W. Veith	Ph: 504-568-3410
			Email: aconne1@lsuhsc.edu
		Robert W. Veith	Principal Investigator
	Ochsner Health Center - Bluebonnet
		John T. Cole	Ph: 888-562-4763
		John T. Cole	Principal Investigator
	Covington
	Ochsner North Shore Medical Center
		John T. Cole	Ph: 888-562-4763
		John T. Cole	Principal Investigator
	New Orleans
	CCOP - Ochsner
		John T. Cole	Ph: 888-562-4763
		John T. Cole	Principal Investigator
	Medical Center of Louisiana - New Orleans
		Robert W. Veith	Ph: 504-568-3410
			Email: aconne1@lsuhsc.edu
		Robert W. Veith	Principal Investigator
	Ochsner Cancer Institute at Ochsner Clinic Foundation
		John T. Cole	Ph: 888-562-4763
		John T. Cole	Principal Investigator
		John T. Cole	Ph: 888-562-4763
		John T. Cole	Principal Investigator
	Stanley S. Scott Cancer Center at Louisiana State University Medical Center - New Orleans
		Robert W. Veith	Ph: 504-568-3410
			Email: aconne1@lsuhsc.edu
		Robert W. Veith	Principal Investigator
	Tulane Cancer Center at Tulane University Hospital and Clinic
		Bridgette M. Collins-Burow	Ph: 504-988-6121
		Bridgette M. Collins-Burow	Principal Investigator
	Shreveport
	Feist-Weiller Cancer Center at Louisiana State University Health Sciences
		Gary V. Burton	Ph: 318-813-1412
		Gary V. Burton	Principal Investigator
	Highland Clinic
		Gary V. Burton	Ph: 318-813-1412
		Gary V. Burton	Principal Investigator
Maine
	Augusta
	Harold Alfond Center for Cancer Care
		Thomas H. Openshaw	Ph: 207-973-4274
		Thomas H. Openshaw	Principal Investigator
	Bangor
	CancerCare of Maine at Eastern Maine Medical Center
		Thomas H. Openshaw	Ph: 207-973-4274
		Thomas H. Openshaw	Principal Investigator
	Rockport
	Penobscot Bay Medical Center
		Thomas H. Openshaw	Ph: 207-973-4274
		Thomas H. Openshaw	Principal Investigator
	Scarborough
	Maine Center for Cancer Medicine and Blood Disorders-Scarborough
		Tracey F. Weisberg	Ph: 207-396-7600
		Tracey F. Weisberg	Principal Investigator
Maryland
	Annapolis
	DeCesaris Cancer Institute at Anne Arundel Medical Center
		Jeanine L. Werner	Ph: 443-481-1320
			Email: kbodenhorn@aahs.org
		Jeanine L. Werner	Principal Investigator
	Baltimore
	Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
		Mayer Gorbaty	Ph: 800-888-8823
		Mayer Gorbaty	Principal Investigator
	Greenebaum Cancer Center at University of Maryland Medical Center
		Katherine H. Tkaczuk	Ph: 800-888-8823
		Katherine H. Tkaczuk	Principal Investigator
	Kaiser Permanente-Woodlawn Medical Center
		Leon C. Hwang	Ph: 301-816-7446
		Leon C. Hwang	Principal Investigator
	Saint Agnes Hospital
		Diana H. Griffiths	Ph: 410-368-2910
		Diana H. Griffiths	Principal Investigator
	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
		Antonio C. Wolff	Ph: 410-955-8804
			Email: jhcccro@jhmi.edu
		Antonio C. Wolff	Principal Investigator
	Bethesda
	Suburban Hospital
		Carolyn B. Hendricks	Ph: 301-896-2719
			Email: Bsquiller@suburbanhospital.org
		Carolyn B. Hendricks	Principal Investigator
	Walter Reed National Military Medical Center
		David C. Van Echo	Ph: 301-319-2100
		David C. Van Echo	Principal Investigator
	Cumberland
	Regional Cancer Center at Western Maryland Health System - Sacred Heart Campus
		Alida I. Podrumar	Ph: 240-964-1400
		Alida I. Podrumar	Principal Investigator
	Easton
	Shore Regional Cancer Center at Memorial Hospital - Easton
		Mary S. De Shields	Ph: 410-820-6800 Ext.108
			Email: srichter@shorehealth.org
		Mary S. De Shields	Principal Investigator
	Elkton MD
	Union Hospital of Cecil County
		David D. Biggs	Ph: 302-733-6227
		David D. Biggs	Principal Investigator
	Gaithersburg
	Kaiser Permanente-Gaithersburg Medical Center
		Leon C. Hwang	Ph: 301-816-7446
		Leon C. Hwang	Principal Investigator
	Largo
	Kaiser Permanente - Largo Medical Center
		Leon C. Hwang	Ph: 301-816-7446
		Leon C. Hwang	Principal Investigator
	Rockville
	Associates in Oncology and Hematology - Medical Center Drive
		Manish Agrawal	Ph: 301-424-6231 Ext.147
			Email: mkalnitskiy@aohmd.com
		Manish Agrawal	Principal Investigator
	Salisbury
	Peninsula Regional Medical Center
		Paul E. Zorsky	Ph: 410-543-7017
			Email: sandra.heineken@peninsula.org
		Paul E. Zorsky	Principal Investigator
Massachusetts
	Attleboro
	Sturdy Memorial Hospital
		Colleen K. Yavarow	Ph: 508-236-7059
		Colleen K. Yavarow	Principal Investigator
	Boston
	Boston University Cancer Research Center
		Maureen T. Kavanah	Ph: 617-638-8265
		Maureen T. Kavanah	Principal Investigator
	Massachusetts General Hospital
		Amy H. Comander	Ph: 617-667-9925
		Amy H. Comander	Principal Investigator
	Tufts Medical Center Cancer Center
		John K. Erban	Ph: 617-636-5000
			Email: ContactUsCancerCenter@TuftsMedicalCenter.org
		John K. Erban	Principal Investigator
	Fairhaven
	Southcoast Centers for Cancer Care-Fairhaven
		Maureen T. Kavanah	Ph: 617-638-8265
		Maureen T. Kavanah	Principal Investigator
	Fall River
	Hudner Oncology Center at Saint Anne's Hospital - Fall River
		James C. Chingos	Ph: 508-674-5600 Ext.2515
		James C. Chingos	Principal Investigator
	Gloucester
	Addison Gilbert Hospital
		Angus P. McIntyre	Ph: 978-283-4000 Ext.559
		Angus P. McIntyre	Principal Investigator
	Peabody
	NSMC Cancer Center - Peabody
		Amy H. Comander	Ph: 617-667-9925
		Amy H. Comander	Principal Investigator
	Pittsfield
	Berkshire Hematology Oncology, PC
		Harvey Zimbler	Ph: 413-496-8205
			Email: Gloria.Gero@berkshirehemonc.com
		Harvey Zimbler	Principal Investigator
	Quincy
	Commonwealth Hematology-Oncology, PC - Quincy
		James R. Everett	Ph: 781-337-9091
		James R. Everett	Principal Investigator
Michigan
	Adrian
	Hickman Cancer Center at Bixby Medical Center
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Ann Arbor
	CCOP - Michigan Cancer Research Consortium
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Saint Joseph Mercy Cancer Center
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	University of Michigan Comprehensive Cancer Center
		Anne F. Schott	Ph: 800-865-1125
		Anne F. Schott	Principal Investigator
	Battle Creek
	Bronson Battle Creek
		Gilbert D. Padula	Ph: 616-685-5225
		Gilbert D. Padula	Principal Investigator
	Bay City
	Bay Regional Medical Center
		Justin F. Klamerus	Ph: 800-248-6777
		Justin F. Klamerus	Principal Investigator
	Big Rapids
	Mecosta County Medical Center
		Gilbert D. Padula	Ph: 616-685-5225
		Gilbert D. Padula	Principal Investigator
	Clarkston
	Great Lakes Cancer Institute
		Justin F. Klamerus	Ph: 800-248-6777
		Justin F. Klamerus	Principal Investigator
	Dearborn
	Oakwood Hospital
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Detroit
	Josephine Ford Cancer Center at Henry Ford Hospital
		Thomas J. Doyle	Ph: 313-916-1784
		Thomas J. Doyle	Principal Investigator
	Van Elslander Cancer Center at St. John Hospital and Medical Center
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Escanaba
	Green Bay Oncology, Limited - Escanaba
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	Flint
	Genesys Hurley Cancer Institute
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Hurley Medical Center
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	McLaren Cancer Institute
		Deimante M. Tamkus	Ph: 517-334-2765
		Deimante M. Tamkus	Principal Investigator
	McLaren Regional Cancer Center
		Justin F. Klamerus	Ph: 800-248-6777
		Justin F. Klamerus	Principal Investigator
	Singh and Arora Hematology Oncology, PC
		Justin F. Klamerus	Ph: 800-248-6777
		Justin F. Klamerus	Principal Investigator
	Grand Rapids
	Butterworth Hospital at Spectrum Health
		Gilbert D. Padula	Ph: 616-685-5225
		Gilbert D. Padula	Principal Investigator
	Grand Rapids Clinical Oncology Program
		Gilbert D. Padula	Ph: 616-685-5225
		Gilbert D. Padula	Principal Investigator
	Lacks Cancer Center at Saint Mary's Health Care
		Gilbert D. Padula	Ph: 616-685-5225
		Gilbert D. Padula	Principal Investigator
	Iron Mountain
	Dickinson County Healthcare System
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	Jackson
	Gayle M. Jacob Cancer Center at Allegiance Health
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Kalamazoo
	Borgess Medical Center
		Raymond S. Lord	Ph: 269-373-7458
		Raymond S. Lord	Principal Investigator
	Bronson Methodist Hospital
		Raymond S. Lord	Ph: 269-373-7458
		Raymond S. Lord	Principal Investigator
	West Michigan Cancer Center
		Raymond S. Lord	Ph: 269-373-7458
		Raymond S. Lord	Principal Investigator
	Lansing
	Breslin Cancer Center at Ingham Regional Medical Center
		Deimante M. Tamkus	Ph: 517-334-2765
		Deimante M. Tamkus	Principal Investigator
		Deimante M. Tamkus	Ph: 517-334-2765
		Deimante M. Tamkus	Principal Investigator
	Sparrow Regional Cancer Center
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Lapeer
	Great Lakes Cancer Institute - Lapeer Campus
		Justin F. Klamerus	Ph: 800-248-6777
		Justin F. Klamerus	Principal Investigator
	Livonia
	St. Mary Mercy Hospital
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Midland
	MidMichigan Medical Center - Midland
		Michel R. Hurtubise	Ph: 989-839-3377
		Michel R. Hurtubise	Principal Investigator
	Monroe
	Community Cancer Center of Monroe
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Mercy Memorial Hospital - Monroe
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Mount Clemens
	Mount Clemens Regional Medical Center
		Justin F. Klamerus	Ph: 800-248-6777
		Justin F. Klamerus	Principal Investigator
	Muskegon
	Mercy General Health Partners
		Gilbert D. Padula	Ph: 616-685-5225
		Gilbert D. Padula	Principal Investigator
	Petoskey
	Northern Michigan Hospital
		Justin F. Klamerus	Ph: 800-248-6777
		Justin F. Klamerus	Principal Investigator
	Pontiac
	St. Joseph Mercy Oakland
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Port Huron
	Mercy Regional Cancer Center at Mercy Hospital
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Reed City
	Spectrum Health Reed City Hospital
		Gilbert D. Padula	Ph: 616-685-5225
		Gilbert D. Padula	Principal Investigator
	Royal Oak
	William Beaumont Hospital - Royal Oak Campus
		Laura M. Nadeau	Ph: 248-551-7695
		Laura M. Nadeau	Principal Investigator
	Saginaw
	Seton Cancer Institute at Saint Mary's - Saginaw
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
	Saint Joseph
	Marie Yeager Cancer Center
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	St. Joseph
	Lakeland Regional Cancer Care Center - St. Joseph
		Naftali Bechar	Ph: 800-777-7775
		Naftali Bechar	Principal Investigator
	Traverse City
	Munson Medical Center
		Gilbert D. Padula	Ph: 616-685-5225
		Gilbert D. Padula	Principal Investigator
	Warren
	St. John Macomb Hospital
		Philip J. Stella	Ph: 734-712-3456
		Philip J. Stella	Principal Investigator
Minnesota
	Bemidji
	Sanford Clinic North-Bemidgi
		Preston D. Steen	Ph: 701-234-6161
		Preston D. Steen	Principal Investigator
	Brainerd
	Essentia Health Saint Joseph's Medical Center
		Daniel A. Nikcevich	Ph: 888-203-7267
		Daniel A. Nikcevich	Principal Investigator
	Burnsville
	Fairview Ridges Hospital
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Coon Rapids
	Mercy and Unity Cancer Center at Mercy Hospital
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Duluth
	Essentia Health - Duluth Clinic
		Daniel A. Nikcevich	Ph: 888-203-7267
		Daniel A. Nikcevich	Principal Investigator
	Essentia Health Duluth Clinic CCOP
		Daniel A. Nikcevich	Ph: 888-203-7267
		Daniel A. Nikcevich	Principal Investigator
	Miller - Dwan Medical Center
		Daniel A. Nikcevich	Ph: 888-203-7267
		Daniel A. Nikcevich	Principal Investigator
	St. Luke's Hospital Cancer Care Center
		Tanya L. Repka	Ph: 888-823-5923
			Email: ctsucontact@westat.com
		Tanya L. Repka	Principal Investigator
	Edina
	Fairview Southdale Hospital
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Fridley
	Mercy and Unity Cancer Center at Unity Hospital
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Hutchinson
	Hutchinson Area Health Care
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Mankato
	Immanuel St. Joseph's
		Mohmmad J. Ranginwala	Ph: 507-385-2929
		Mohmmad J. Ranginwala	Principal Investigator
	Maplewood
	HealthEast Cancer Care at St. John's Hospital
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Minnesota Oncology - Maplewood
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Minneapolis
	Hennepin County Medical Center - Minneapolis
		Richard T. Zera	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Richard T. Zera	Principal Investigator
	Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	New Ulm
	New Ulm Medical Center
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Robbinsdale
	Humphrey Cancer Center at North Memorial Outpatient Center
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Saint Cloud
	CentraCare Clinic - River Campus
		Donald J. Jurgens	Ph: 877-229-4907
			Email: coborncancercenter@centracare.com
		Donald J. Jurgens	Principal Investigator
	Coborn Cancer Center
		Donald J. Jurgens	Ph: 877-229-4907
			Email: coborncancercenter@centracare.com
		Donald J. Jurgens	Principal Investigator
	Saint Louis Park
	CCOP - Metro-Minnesota
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Park Nicollet Cancer Center
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Saint Paul
	Regions Hospital Cancer Care Center
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	United Hospital
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Shakopee
	St. Francis Cancer Center at St. Francis Medical Center
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Stillwater
	Lakeview Hospital
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Waconia
	Ridgeview Medical Center
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Willmar
	Willmar Cancer Center at Rice Memorial Hospital
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
	Woodbury
	Minnesota Oncology - Woodbury
		Patrick J. Flynn	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Patrick J. Flynn	Principal Investigator
Mississippi
	Gulfport
	Gulfport Memorial Hospital
		Robert W. Veith	Ph: 504-568-3410
			Email: aconne1@lsuhsc.edu
		Robert W. Veith	Principal Investigator
	Jackson
	University of Mississippi Cancer Clinic
		Barbara S. Craft	Ph: 601-815-6700
		Barbara S. Craft	Principal Investigator
	Pascagoula
	Regional Cancer Center at Singing River Hospital
		James E. Clarkson	Ph: 228-809-5292
		James E. Clarkson	Principal Investigator
Missouri
	Bolivar
	Central Care Cancer Center at Carrie J. Babb Cancer Center
		Robert L. Carolla	Ph: 417-269-4520
		Robert L. Carolla	Principal Investigator
	Cape Girardeau
	Saint Francis Medical Center
		Bethany G. Sleckman	Ph: 913-948-5588
		Bethany G. Sleckman	Principal Investigator
	Southeast Cancer Center
		Alan P. Lyss	Ph: 800-392-0936
		Alan P. Lyss	Principal Investigator
	Chesterfield
	Saint Luke's Hospital
		Donald F. Busiek	Ph: 314-205-6936
		Donald F. Busiek	Principal Investigator
	Columbia
	Ellis Fischel Cancer Center at University of Missouri - Columbia
		Carl G. Kardinal	Ph: 573-882-7440
		Carl G. Kardinal	Principal Investigator
	Jefferson City
	Capital Region Medical Center-Goldschmidt Cancer Center
		Alan P. Lyss	Ph: 800-392-0936
		Alan P. Lyss	Principal Investigator
	Joplin
	Freeman Cancer Institute at Freeman Health System
		John H. Vu	Ph: 417-347-4030
		John H. Vu	Principal Investigator
	Rolla
	Phelps County Regional Medical Center
		Robert L. Carolla	Ph: 417-269-4520
		Robert L. Carolla	Principal Investigator
	Saint John's Clinic-Rolla-Cancer and Hematology
		Robert L. Carolla	Ph: 417-269-4520
		Robert L. Carolla	Principal Investigator
	Saint Louis
	CCOP - St. Louis-Cape Girardeau
		Bethany G. Sleckman	Ph: 913-948-5588
		Bethany G. Sleckman	Principal Investigator
	David C. Pratt Cancer Center at St. John's Mercy
		Bethany G. Sleckman	Ph: 913-948-5588
		Bethany G. Sleckman	Principal Investigator
	Missouri Baptist Cancer Center
		Alan P. Lyss	Ph: 800-392-0936
		Alan P. Lyss	Principal Investigator
	Saint Louis Cancer and Breast Institute-South City
		Bethany G. Sleckman	Ph: 913-948-5588
		Bethany G. Sleckman	Principal Investigator
	Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
		Timothy J. Pluard	Ph: 800-600-3606
			Email: info@siteman.wustl.edu
		Timothy J. Pluard	Principal Investigator
	Springfield
	Cancer Research for the Ozarks
		Robert L. Carolla	Ph: 417-269-4520
		Robert L. Carolla	Principal Investigator
	Hulston Cancer Center at Cox Medical Center South
		Robert L. Carolla	Ph: 417-269-4520
		Robert L. Carolla	Principal Investigator
	St. John's Regional Health Center
		Robert L. Carolla	Ph: 417-269-4520
		Robert L. Carolla	Principal Investigator
Montana
	Billings
	Billings Clinic Cancer Center
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	CCOP - Montana Cancer Consortium
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	Hematology-Oncology Centers of the Northern Rockies PC
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	St. Vincent Healthcare Cancer Care Services
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	Bozeman
	Bozeman Deaconess Cancer Center
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	Butte
	St. James Healthcare Cancer Care
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	Great Falls
	Benefis Sletten Cancer Institute
		Grant W. Harrer	Ph: 406-731-8217
		Grant W. Harrer	Principal Investigator
	Helena
	St. Peter's Hospital
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	Kalispell
	Kalispell Regional Medical Center
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	Missoula
	Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	Montana Cancer Specialists at Montana Cancer Center
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
Nebraska
	Kearney
	Good Samaritan Cancer Center at Good Samaritan Hospital
		George K. Bascom	Ph: 308-865-7963
		George K. Bascom	Principal Investigator
	Lincoln
	Cancer Resource Center - Lincoln
		Gamini S. Soori	Ph: 800-253-4368
		Gamini S. Soori	Principal Investigator
	Omaha
	Alegant Health Cancer Center at Bergan Mercy Medical Center
		Gamini S. Soori	Ph: 800-253-4368
		Gamini S. Soori	Principal Investigator
	CCOP - Missouri Valley Cancer Consortium
		Gamini S. Soori	Ph: 800-253-4368
		Gamini S. Soori	Principal Investigator
	Creighton University Medical Center
		Gamini S. Soori	Ph: 800-253-4368
		Gamini S. Soori	Principal Investigator
	Immanuel Medical Center
		Gamini S. Soori	Ph: 800-253-4368
		Gamini S. Soori	Principal Investigator
	Lakeside Hospital
		Gamini S. Soori	Ph: 800-253-4368
		Gamini S. Soori	Principal Investigator
	Methodist Estabrook Cancer Center
		James A. Reilly	Ph: 402-354-5144
		James A. Reilly	Principal Investigator
Nevada
	Las Vegas
	CCOP - Nevada Cancer Research Foundation
		John A. Ellerton	Ph: 702-731-8274
		John A. Ellerton	Principal Investigator
	University Medical Center of Southern Nevada
		John A. Ellerton	Ph: 702-731-8274
		John A. Ellerton	Principal Investigator
New Hampshire
	Concord
	New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
		Frederick M. Briccetti	Ph: 800-339-6484
		Frederick M. Briccetti	Principal Investigator
	Hooksett
	New Hampshire Oncology - Hematology, PA - Hooksett
		Frederick M. Briccetti	Ph: 800-339-6484
		Frederick M. Briccetti	Principal Investigator
	Laconia
	Lakes Region General Hospital
		Frederick M. Briccetti	Ph: 800-339-6484
		Frederick M. Briccetti	Principal Investigator
	Lebanon
	Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
		Mary D. Chamberlin	Ph: 800-639-6918
			Email: cancer.research.nurse@dartmouth.edu
		Mary D. Chamberlin	Principal Investigator
New Jersey
	Camden
	Cancer Institute of New Jersey at Cooper University Hospital - Camden
		David D. Biggs	Ph: 302-733-6227
		David D. Biggs	Principal Investigator
	Flemington
	Hunterdon Regional Cancer Center at Hunterdon Medical Center
		Kenneth B. Blankstein	Ph: 888-788-1260
		Kenneth B. Blankstein	Principal Investigator
	Livingston
	St. Barnabas Medical Center Cancer Center
		Richard A. Michaelson	Ph: 973-322-2470
		Richard A. Michaelson	Principal Investigator
	Long Branch
	Monmouth Medical Center
		David J. Sharon	Ph: 732-923-7689
		David J. Sharon	Principal Investigator
	Morristown
	Carol G. Simon Cancer Center at Morristown Memorial Hospital
		Bonni L. Guerin	Ph: 908-522-2043
		Bonni L. Guerin	Principal Investigator
	Mount Holly
	Virtua Fox Chase Health Cancer Program at Virtua Memorial Hospital Burlington County
		Michael S. Entmacher	Ph: 888-847-8823
		Michael S. Entmacher	Principal Investigator
	Newark
	Newark Beth Israel Medical Center
		Frederick B. Cohen	Ph: 973-926-7230
		Frederick B. Cohen	Principal Investigator
	UMDNJ - New Jersey Medical School
		Margarette R. N. Bryan	Ph: 732-235-8675
		Margarette R. N. Bryan	Principal Investigator
	Paterson
	St. Joseph's Hospital and Medical Center
		Michael Maroules	Ph: 973-754-2909
		Michael Maroules	Principal Investigator
	Somerville
	Somerset Medical Center
		Kathleen C. Toomey	Ph: 908-685-2481
		Kathleen C. Toomey	Principal Investigator
	Sparta
	Frederick R. and Betty M. Smith Cancer Treatment Center
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	Summit
	Overlook Hospital
		Bonni L. Guerin	Ph: 908-522-2043
		Bonni L. Guerin	Principal Investigator
	Toms River
	J. Phillip Citta Regional Cancer Center at Community Medical Center
		Sudha Kavuru	Ph: 732-818-3882
		Sudha Kavuru	Principal Investigator
	Vineland
	South Jersey Healthcare Regional Medical Center
		Benjamin P. Negin	Ph: 856-641-7933
		Benjamin P. Negin	Principal Investigator
	Voorhees
	Fox Chase Virtua Health Cancer Program at Virtua West Jersey
		Michael S. Entmacher	Ph: 888-847-8823
		Michael S. Entmacher	Principal Investigator
New Mexico
	Albuquerque
	Hematology Oncology Associates, PC
		Melanie E. Royce	Ph: 505-727-8000
		Melanie E. Royce	Principal Investigator
	Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
		Melanie E. Royce	Ph: 505-727-8000
		Melanie E. Royce	Principal Investigator
	University of New Mexico Cancer Center
		Melanie E. Royce	Ph: 505-727-8000
		Melanie E. Royce	Principal Investigator
		Melanie E. Royce	Ph: 505-727-8000
		Melanie E. Royce	Principal Investigator
	Las Cruces
	Memorial Medical Center
		Melanie E. Royce	Ph: 505-727-8000
		Melanie E. Royce	Principal Investigator
New York
	Albany
	New York Oncology Hematology PC - Albany
		Regina Resta	Ph: 518-489-3612 Ext.1342
			Email: sharon.krause@usoncology.com
		Regina Resta	Principal Investigator
	New York Oncology Hematology PC -Albany Medical Center
		Regina Resta	Ph: 518-489-3612 Ext.1342
			Email: sharon.krause@usoncology.com
		Regina Resta	Principal Investigator
	Saint Peters Hospital-Albany
		Stephen H. Wrzesinski	Ph: 518-525-1547
		Stephen H. Wrzesinski	Principal Investigator
	Amsterdam
	New York Oncology Hematology PC - Amsterdam
		Regina Resta	Ph: 518-489-3612 Ext.1342
			Email: sharon.krause@usoncology.com
		Regina Resta	Principal Investigator
	Bronx
	Albert Einstein Cancer Center at Albert Einstein College of Medicine
		Christine M. Pellegrino	Ph: 718-904-2730
			Email: aecc@aecom.yu.edu
		Christine M. Pellegrino	Principal Investigator
		Christine M. Pellegrino	Ph: 718-904-2730
			Email: aecc@aecom.yu.edu
		Christine M. Pellegrino	Principal Investigator
	Buffalo
	Roswell Park Cancer Institute
		Ellis G. Levine	Ph: 877-275-7724
		Ellis G. Levine	Principal Investigator
	Cooperstown
	Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
		Eric Bravin	Ph: 607-547-6965
			Email: jennifer.victory@bassett.org
		Eric Bravin	Principal Investigator
	East Syracuse
	Hematology Oncology Associates of Central New York, PC - Northeast Center
		Jeffrey J. Kirshner	Ph: 315-472-7504
		Jeffrey J. Kirshner	Principal Investigator
	Elmhurst
	Elmhurst Hospital Center
		Mary M. Kemeny	Ph: 718-883-3000
		Mary M. Kemeny	Principal Investigator
	Elmira
	Arnot Ogden Medical Center
		Jonathan W. Friedberg	Ph: 585-275-5830
		Jonathan W. Friedberg	Principal Investigator
	Glens Falls
	Charles R. Wood Cancer Center at Glens Falls Hospital
		Robert W. Sponzo	Ph: 518-926-6700
		Robert W. Sponzo	Principal Investigator
	Hudson
	New York Oncology Hematology PC-Hudson
		Regina Resta	Ph: 518-489-3612 Ext.1342
			Email: sharon.krause@usoncology.com
		Regina Resta	Principal Investigator
	Jamaica
	Queens Cancer Center of Queens Hospital
		Mary M. Kemeny	Ph: 718-883-3000
		Mary M. Kemeny	Principal Investigator
	Latham
	New York Oncology Hematology PC - Latham
		Regina Resta	Ph: 518-489-3612 Ext.1342
			Email: sharon.krause@usoncology.com
		Regina Resta	Principal Investigator
	Middletown
	Tucker Center for Cancer Care at Orange Regional Medical Center
		Jeffrey M. Stewart	Ph: 845-342-7609
		Jeffrey M. Stewart	Principal Investigator
	Mineola
	Winthrop University Hospital
		Nina D'Abreo	Ph: 866-946-8476
		Nina D'Abreo	Principal Investigator
	Mount Kisco
	Mount Kisco Medical Group, PC
		Jonathan S. Goldberg	Ph: 914-666-1366
			Email: skloiber@nwhc.net
		Jonathan S. Goldberg	Principal Investigator
	New York
	Beth Israel Medical Center - Philipps Ambulatory Care Center
		Paula Klein	Ph: 212-367-1729
		Paula Klein	Principal Investigator
	St. Luke's - Roosevelt Hospital Center - St.Luke's Division
		Paula Klein	Ph: 212-367-1729
		Paula Klein	Principal Investigator
	Plattsburgh
	Fitzpatrick Cancer Center at Champlain Valley Physicians Hospital Medical Center
		Jan E. Duus	Ph: 518-561-2000
		Jan E. Duus	Principal Investigator
	Poughkeepsie
	Dyson Center for Cancer Care at Vassar Brothers Medical Center
		Radhika Rachamalla	Ph: 845-483-5997
			Email: Cancer@sfhhc.org
		Radhika Rachamalla	Principal Investigator
	Saint Francis
		Theodora S. Budnik	Ph: 845-483-5997
			Email: Cancer@sfhhc.org
		Theodora S. Budnik	Principal Investigator
	Rexford
	New York Oncology Hematology PC - Rexford
		Regina Resta	Ph: 518-489-3612 Ext.1342
			Email: sharon.krause@usoncology.com
		Regina Resta	Principal Investigator
	Rochester
	Highland Hospital of Rochester
		Jonathan W. Friedberg	Ph: 585-275-5830
		Jonathan W. Friedberg	Principal Investigator
	James P. Wilmot Cancer Center at University of Rochester Medical Center
		Jonathan W. Friedberg	Ph: 585-275-5830
		Jonathan W. Friedberg	Principal Investigator
	Staten Island
	Nalitt Cancer Institute at Staten Island University Hospital
		Terenig O. Terjanian	Ph: 718-226-8888
		Terenig O. Terjanian	Principal Investigator
	Stony Brook
	Stony Brook University Cancer Center
		Andrzej P. Kudelka	Ph: 800-862-2215
		Andrzej P. Kudelka	Principal Investigator
	Syracuse
	SUNY Upstate Medical University Hospital
		Sheila M. Lemke	Ph: 315-464-5476
		Sheila M. Lemke	Principal Investigator
	Troy
	New York Oncology Hematology PC - Troy
		Regina Resta	Ph: 518-489-3612 Ext.1342
			Email: sharon.krause@usoncology.com
		Regina Resta	Principal Investigator
	White Plains
	Dickstein Cancer Treatment Center at White Plains Hospital Center
		Mark A. Fialk	Ph: 888-823-5923
			Email: ctsucontact@westat.com
		Mark A. Fialk	Principal Investigator
North Carolina
	Asheville
	Hope, A Women's Cancer Center
		David J. Hetzel	Ph: 828-670-8403
		David J. Hetzel	Principal Investigator
	Mission Hospitals - Memorial Campus
		Michael J. Messino	Ph: 828-213-4150
		Michael J. Messino	Principal Investigator
	Burlington
	Alamance Cancer Center at Alamance Regional Medical Center
		Janak K. Choksi	Ph: 336-538-7725
		Janak K. Choksi	Principal Investigator
	Chapel Hill
	Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
		Elizabeth C. Dees	Ph: 877-668-0683
		Elizabeth C. Dees	Principal Investigator
	Charlotte
	Blumenthal Cancer Center at Carolinas Medical Center
		Steven A. Limentani	Ph: 704-355-2884
		Steven A. Limentani	Principal Investigator
	Presbyterian Cancer Center at Presbyterian Hospital
		Justin P. Favaro	Ph: 704-384-5369
		Justin P. Favaro	Principal Investigator
	Concord
	Carolinas Medical Center - Northeast
		Steven A. Limentani	Ph: 704-355-2884
		Steven A. Limentani	Principal Investigator
	Durham
	Duke Cancer Institute
		Jeffrey Crawford	Ph: 888-275-3853
		Jeffrey Crawford	Principal Investigator
	Fayetteville
	Cape Fear Valley Health System
		Kamal M. Bakri	Ph: 910-609-4561
		Kamal M. Bakri	Principal Investigator
	Gastonia
	CaroMont Cancer Center at Gaston Memorial Hospital
		Steven W. Yates	Ph: 704-834-2932
		Steven W. Yates	Principal Investigator
	Goldsboro
	Wayne Memorial Hospital, Incorporated
		James N. Atkins	Ph: 919-580-0000
		James N. Atkins	Principal Investigator
	Hendersonville
	Pardee Memorial Hospital
		James E. Radford	Ph: 828-696-4716
		James E. Radford	Principal Investigator
	Park Ridge Hospital Breast Health Center
		Steven W. Corso	Ph: 800-486-5941
		Steven W. Corso	Principal Investigator
	Kinston
	Kinston Medical Specialists
		Peter R. Watson	Ph: 252-559-2200
		Peter R. Watson	Principal Investigator
	Lumberton
	Southeastern Regional Medical Center
		Jeffrey Crawford	Ph: 888-275-3853
		Jeffrey Crawford	Principal Investigator
	Monroe
	Carolinas Medical Center-Union
		Steven A. Limentani	Ph: 704-355-2884
		Steven A. Limentani	Principal Investigator
	Oxford
	Granville Medical Center
		Jeffrey Crawford	Ph: 888-275-3853
		Jeffrey Crawford	Principal Investigator
	Raleigh
	Duke Health Raleigh Hospital
		Jeffrey Crawford	Ph: 888-275-3853
		Jeffrey Crawford	Principal Investigator
	Rex Cancer Center at Rex Hospital
		Jeremiah C. Boles	Ph: 919-784-7209
		Jeremiah C. Boles	Principal Investigator
	Rex Cancer Center of Wakefield
		Robert S. Wehbie	Ph: 877-668-0683
		Robert S. Wehbie	Principal Investigator
	Roxboro
	Person Memorial Hospital
		Jeffrey Crawford	Ph: 888-275-3853
		Jeffrey Crawford	Principal Investigator
	Rutherfordton
	Rutherford Hospital
		Steven W. Corso	Ph: 800-486-5941
		Steven W. Corso	Principal Investigator
	Shelby
	Cleveland Regional Medical Center
		Steven A. Limentani	Ph: 704-355-2884
		Steven A. Limentani	Principal Investigator
	Statesville
	Iredell Memorial Hospital
		Ruby A. Grimm	Ph: 704-873-5661
		Ruby A. Grimm	Principal Investigator
	Washington
	Marion L. Shepard Cancer Center at Beaufort County Hospital
		John J. Inzerillo	Ph: 252-975-4308 Ext.104
			Email: sbell@brhealthsystem.org
		John J. Inzerillo	Principal Investigator
	Winston-Salem
	Forsyth Memorial Hospital
		Judith O. Hopkins	Ph: 336-277-8887
		Judith O. Hopkins	Principal Investigator
North Dakota
	Bismarck
	Mid Dakota Clinic, PC
		John T. Reynolds	Ph: 701-323-5760
			Email: tfischer@mohs.org
		John T. Reynolds	Principal Investigator
	Sanford Bismarck Medical Center
		John T. Reynolds	Ph: 701-323-5760
			Email: tfischer@mohs.org
		John T. Reynolds	Principal Investigator
	St. Alexius Medical Center Cancer Center
		John T. Reynolds	Ph: 701-323-5760
			Email: tfischer@mohs.org
		John T. Reynolds	Principal Investigator
	Fargo
	Essentia Health Cancer Center-South University Clinic
		Daniel A. Nikcevich	Ph: 888-203-7267
		Daniel A. Nikcevich	Principal Investigator
	Roger Maris Cancer Center at MeritCare Hospital
		Preston D. Steen	Ph: 701-234-6161
		Preston D. Steen	Principal Investigator
	Sanford Clinic North-Fargo
		Preston D. Steen	Ph: 701-234-6161
		Preston D. Steen	Principal Investigator
	Sanford Medical Center-Fargo
		Preston D. Steen	Ph: 701-234-6161
		Preston D. Steen	Principal Investigator
	Grand Forks
	Altru Cancer Center at Altru Hospital
		Grant R. Seeger	Ph: 701-780-6520
		Grant R. Seeger	Principal Investigator
Ohio
	Akron
	Summa Center for Cancer Care at Akron City Hospital
		Michael J. Seider	Ph: 330-615-4132
		Michael J. Seider	Principal Investigator
	Barberton
	Barberton Citizens Hospital
		Michael J. Seider	Ph: 330-615-4132
		Michael J. Seider	Principal Investigator
	Bowling Green
	Toledo Clinic Cancer Centers-Bowling Green
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Canton
	Aultman Cancer Center at Aultman Hospital
		Shruti Trehan	Ph: 330-363-6891
		Shruti Trehan	Principal Investigator
	Chillicothe
	Adena Regional Medical Center
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Cincinnati
	Charles M. Barrett Cancer Center at University Hospital
		Elizabeth A. Shaughnessy	Ph: 513-558-4553
			Email: uchealthnews@uc.edu
		Elizabeth A. Shaughnessy	Principal Investigator
	Cleveland
	Case Comprehensive Cancer Center
		Rosemary Leeming	Ph: 800-641-2422
		Rosemary Leeming	Principal Investigator
	MetroHealth Cancer Care Center at MetroHealth Medical Center
		Bruce J. Averbook	Ph: 216-778-8526
			Email: kbauchens@metrohealth.org
		Bruce J. Averbook	Principal Investigator
	Columbus
	Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
		William B. Farrar	Ph: 866-627-7616
			Email: osu@emergingmed.com
		William B. Farrar	Principal Investigator
	CCOP - Columbus
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Doctors Hospital at Ohio Health
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Grant Medical Center Cancer Care
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Mount Carmel Health - West Hospital
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Riverside Methodist Hospital Cancer Care
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Zangmeister Center
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Dayton
	David L. Rike Cancer Center at Miami Valley Hospital
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Dayton CCOP
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Good Samaritan Hospital
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Grandview Hospital
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Samaritan North Cancer Care Center
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Delaware
	Grady Memorial Hospital
		John P. Kuebler	Ph: 614-566-3275
		John P. Kuebler	Principal Investigator
	Elyria
	Hematology Oncology Center
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Findlay
	Blanchard Valley Regional Cancer Center
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Franklin
	Atrium Medical Center
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Greenville
	Wayne Hospital
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Kettering
	Charles F. Kettering Memorial Hospital
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Lancaster
	Fairfield Medical Center
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Lima
	Lima Memorial Hospital
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	St. Rita's Medical Center
		Henry Gerad	Ph: 419-226-9617
		Henry Gerad	Principal Investigator
	Mansfield
	MedCentral - Mansfield Hospital
		Robert E. Exten	Ph: 419-526-8938
		Robert E. Exten	Principal Investigator
	Marietta
	Strecker Cancer Center at Marietta Memorial Hospital
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Maumee
	Northwest Ohio Oncology Center
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Toledo Clinic Cancer Centers-Maumee
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Mount Vernon
	Knox Community Hospital
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Newark
	Licking Memorial Cancer Care Program at Licking Memorial Hospital
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Oregon
	St. Charles Hospital
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Toledo Clinic Cancer Centers-Oregon
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Portsmouth
	Southern Ohio Medical Center
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Springfield
	Springfield Regional Medical Center
		John P. Kuebler	Ph: 614-566-3275
		John P. Kuebler	Principal Investigator
	Sylvania
	Flower Hospital
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Tiffin
	Mercy Hospital of Tiffin
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Toledo
	CCOP - Toledo Community Hospital
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	St. Anne Mercy Hospital
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	St. Vincent Mercy Medical Center
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	The Toledo Hospital/Toledo Children's Hospital
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Toledo Clinic Cancer Centers-Toledo
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	University of Toledo Medical Center
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Troy
	UVMC Cancer Care Center at Upper Valley Medical Center
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Wauseon
	Fulton County Health Center
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Westerville
	Mount Carmel St. Ann's Cancer Center
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
	Wright-Patterson Afb
	United States Air Force Medical Center - Wright-Patterson
		Brandon J. Cutler	Ph: 937-257-1398
		Brandon J. Cutler	Principal Investigator
	Xenia
	Ruth G. McMillan Cancer Center at Greene Memorial Hospital
		Howard M. Gross	Ph: 317-783-8918
		Howard M. Gross	Principal Investigator
	Zanesville
	Genesis - Good Samaritan Hospital
		John P. Kuebler	Ph: 502-361-8496
		John P. Kuebler	Principal Investigator
Oklahoma
	Lawton
	Cancer Centers of Southwest Oklahoma Research
		Nadim F. Nimeh	Ph: 877-231-4440
		Nadim F. Nimeh	Principal Investigator
	Oklahoma City
	Integris Cancer Institute of Oklahoma
		Romeo A. Mandanas	Ph: 405-949-3870
		Romeo A. Mandanas	Principal Investigator
	Oklahoma University Cancer Institute
		Carla Kurkjian	Ph: 405-271-4272
			Email: julie-traylor@ouhsc.edu
		Carla Kurkjian	Principal Investigator
	Tulsa
	Natalie Warren Bryant Cancer Center at St. Francis Hospital
		James B. Lockhart	Ph: 918-494-2200
		James B. Lockhart	Principal Investigator
Oregon
	Glesham
	Legacy Mount Hood Medical Center
		Jay C. Andersen	Ph: 800-220-4937
		Jay C. Andersen	Principal Investigator
	Grants Pass
	Three Rivers Community Hospital
		Charles R. Dibb	Ph: 541-789-6176
		Charles R. Dibb	Principal Investigator
	Medford
	Providence Medford Medical Center
		Charles R. Dibb	Ph: 541-789-6176
		Charles R. Dibb	Principal Investigator
	Rogue Valley Medical Center
		Charles R. Dibb	Ph: 541-789-6176
		Charles R. Dibb	Principal Investigator
	Portland
	Kaiser Permanente Medical Office - Interstate Medical Office Central
		Nagendra R. Tirumali	Ph: 503-335-2400
		Nagendra R. Tirumali	Principal Investigator
	Legacy Good Samaritan Hospital & Comprehensive Cancer Center
		Jay C. Andersen	Ph: 800-220-4937
		Jay C. Andersen	Principal Investigator
	Salem
	Salem Hospital Regional Cancer Care Services
		John Strother	Ph: 503-561-2618
		John Strother	Principal Investigator
	The Dalles
	Mid-Columbia Medical Center
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Tualatin
	Legacy Meridian Park Hospital
		Jay C. Andersen	Ph: 800-220-4937
		Jay C. Andersen	Principal Investigator
Pennsylvania
	Abington
	Rosenfeld Cancer Center at Abington Memorial Hospital
		Willard G. Andrews	Ph: 215-481-2402
		Willard G. Andrews	Principal Investigator
	Allentown
	Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
		Lori C. Alfonse	Ph: 610-402-2273
		Lori C. Alfonse	Principal Investigator
	Bryn Mawr
	Bryn Mawr Hospital
		Paul B. Gilman	Ph: 484-476-2649
			Email: wellenbachj@mlhs.org
		Paul B. Gilman	Principal Investigator
	Danville
	Geisinger Cancer Institute at Geisinger Health
		James F. Evans	Ph: 570-271-5251
		James F. Evans	Principal Investigator
	Darby
	Mercy Fitzgerald Hospital
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	Doylestown
	Doylestown Hospital Cancer Center
		Mitchell B. Alden	Ph: 215-345-2378
			Email: lheacock@dh.org
		Mitchell B. Alden	Principal Investigator
	Drexel Hill
	Delaware County Regional Cancer Center at Delaware County Memorial Hospital
		Stephen A. Shore	Ph: 610-284-8237
			Email: jolene.garney@crozer.org
		Stephen A. Shore	Principal Investigator
	Dubois
	Oncology Hematology Associates of Northern Pennsylvania
		Thomas B. Julian	Ph: 877-284-2000
		Thomas B. Julian	Principal Investigator
	East Stroudsburg
	Dale and Frances Hughes Cancer Center at Pocono Medical Center
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	Easton
	Easton Regional Cancer Center at Easton Hospital
		Rajen P. Oza	Ph: 610-250-4000
		Rajen P. Oza	Principal Investigator
	Ephrata
	Ephrata Cancer Center at Ephrata Community Hospital
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	Harrisburg
	PinnacleHealth Fox Chase Regional Cancer Center at Polyclinic Hospital
		Roy A. Williams	Ph: 717-724-6765
			Email: klitchfield@PINNACLEHEALTH.org
		Roy A. Williams	Principal Investigator
	Hazleton
	Geisinger Medical Center-Cancer Center Hazelton
		James F. Evans	Ph: 570-271-5251
		James F. Evans	Principal Investigator
	Hershey
	Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
		Harold A. Harvey	Ph: 717-531-3779
			Email: CTO@hmc.psu.edu
		Harold A. Harvey	Principal Investigator
	Langhorne
	St. Mary Regional Cancer Center
		Robert E. Reilly	Ph: 215-710-4585
		Robert E. Reilly	Principal Investigator
	Meadowbrook
	Holy Redeemer Hospital and Medical Center
		Pallav Mehta	Ph: 215-938-3551
		Pallav Mehta	Principal Investigator
	Media
	Riddle Memorial Hospital Cancer Center
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	Monroeville
	Forbes Regional Hospital
		Thomas B. Julian	Ph: 877-284-2000
		Thomas B. Julian	Principal Investigator
	Natrona Heights
	Alle-Kiski Medical Center
		Thomas B. Julian	Ph: 877-284-2000
		Thomas B. Julian	Principal Investigator
	Norristown
	Mercy Suburban Cancer Center
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	Paoli
	Cancer Center of Paoli Memorial Hospital
		Paul B. Gilman	Ph: 484-476-2649
			Email: wellenbachj@mlhs.org
		Paul B. Gilman	Principal Investigator
	Philadelphia
	Albert Einstein Cancer Center
		Ajit M. Desai	Ph: 215-456-3880
		Ajit M. Desai	Principal Investigator
	Fox Chase Cancer Center CCOP Research Base
		Aruna Padmanabhan	Ph: 215-728-2983
		Aruna Padmanabhan	Principal Investigator
	Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	Mercy Hospital of Philadelphia
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	Pittsburgh
	Allegheny Cancer Center at Allegheny General Hospital
		Thomas B. Julian	Ph: 877-284-2000
		Thomas B. Julian	Principal Investigator
	UPMC Cancer Centers
		Adam M. Brufsky	Ph: 412-647-2811
		Adam M. Brufsky	Principal Investigator
	Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
		Thomas B. Julian	Ph: 877-284-2000
		Thomas B. Julian	Principal Investigator
	Pottstown
	Pottstown Memorial Regional Cancer Center
		Wei F. Song	Ph: 610-327-7544
		Wei F. Song	Principal Investigator
	Reading
	St. Joseph Medical Center
		Marc A. Rovito	Ph: 610-378-2336
			Email: kevinkeller@catholichealth.net
		Marc A. Rovito	Principal Investigator
	Sayre
	Guthrie Clinic-Robert Packer Hospital
		Cynthia A. Lynch	Ph: 800-836-0388
		Cynthia A. Lynch	Principal Investigator
	Scranton
	Hematology and Oncology Associates of Northeastern Pennsylvania
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	Mercy Hospital Cancer Center - Scranton
		Martin Hyzinski	Ph: 570-558-3020
		Martin Hyzinski	Principal Investigator
	Scranton Hematology Oncology
		Martin Hyzinski	Ph: 570-558-3020
		Martin Hyzinski	Principal Investigator
	Sellersville
	Grand View Hospital
		Anthony J. Magdalinski	Ph: 215-453-4162
			Email: PParsons@gvh.org
		Anthony J. Magdalinski	Principal Investigator
	State College
	Geisinger Medical Group - Scenery Park
		James F. Evans	Ph: 570-271-5251
		James F. Evans	Principal Investigator
	Mount Nittany Medical Center
		John P. Ford	Ph: 814-231-7813
			Email: smoyer@mountnittany.org
		John P. Ford	Principal Investigator
	Upland
	Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center
		Allison Zibelli	Ph: 215-955-6084
		Allison Zibelli	Principal Investigator
	West Chester
	Chester County Hospital
		William E. Luginbuhl	Ph: 610-431-5297
		William E. Luginbuhl	Principal Investigator
	West Reading
	McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
		Debra M. Ray	Ph: 732-923-7689
		Debra M. Ray	Principal Investigator
	Wilkes-Barre
	Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
		James F. Evans	Ph: 570-271-5251
		James F. Evans	Principal Investigator
	Williamsport
	Susquehanna Cancer Center
		Warren L. Robinson	Ph: 800-598-4282
		Warren L. Robinson	Principal Investigator
	Wynnewood
	CCOP - Main Line Health
		Paul B. Gilman	Ph: 484-476-2649
			Email: wellenbachj@mlhs.org
		Paul B. Gilman	Principal Investigator
	Lankenau Cancer Center at Lankenau Hospital
		Paul B. Gilman	Ph: 484-476-2649
			Email: wellenbachj@mlhs.org
		Paul B. Gilman	Principal Investigator
Rhode Island
	Providence
	Miriam Hospital
		William M. Sikov	Ph: 401-793-2224
		William M. Sikov	Principal Investigator
	Rhode Island Hospital Comprehensive Cancer Center
		William M. Sikov	Ph: 401-793-2224
		William M. Sikov	Principal Investigator
	Women and Infants Hospital of Rhode Island
		Bachir J. Sakr	Ph: 401-274-1122
		Bachir J. Sakr	Principal Investigator
	Warwick
	Kent County Memorial Hospital
		Michael C. Coburn	Ph: 401-737-7010
		Michael C. Coburn	Principal Investigator
South Carolina
	Anderson
	AnMed Cancer Center
		Steven W. Corso	Ph: 800-486-5941
		Steven W. Corso	Principal Investigator
	Beaufort
	Beaufort Memorial Hospital
		Majd Chahin	Ph: 843-522-7819
		Majd Chahin	Principal Investigator
	Charleston
	Hollings Cancer Center at Medical University of South Carolina
		Rita M. Kramer	Ph: 843-792-9321
		Rita M. Kramer	Principal Investigator
	Roper Hospital
		James M. Orcutt	Ph: 843-720-8386
			Email: elizabeth.strojny@roperstfrancis.com
		James M. Orcutt	Principal Investigator
	Georgetown
	Georgetown Hospital System
		Rita M. Kramer	Ph: 843-792-9321
		Rita M. Kramer	Principal Investigator
	Greenville
	Batson Cancer Care Center at St. Francis Hospital
		Steven W. Corso	Ph: 800-486-5941
		Steven W. Corso	Principal Investigator
	Cancer Centers of the Carolinas - Faris
		Jeffrey K. Giguere	Ph: 864-241-6251
		Jeffrey K. Giguere	Principal Investigator
	Cancer Centers of the Carolinas - Grove Commons
		Jeffrey K. Giguere	Ph: 864-241-6251
		Jeffrey K. Giguere	Principal Investigator
	CCOP - Greenville
		Jeffrey K. Giguere	Ph: 864-241-6251
		Jeffrey K. Giguere	Principal Investigator
	Greenville Hospital Cancer Center
		Jeffrey K. Giguere	Ph: 864-241-6251
		Jeffrey K. Giguere	Principal Investigator
	Greenwood
	Self Regional Healthcare
		Rita M. Kramer	Ph: 843-792-9321
		Rita M. Kramer	Principal Investigator
	Greer
	Cancer Centers of the Carolinas-Greer Medical Oncology
		Jeffrey K. Giguere	Ph: 864-241-6251
		Jeffrey K. Giguere	Principal Investigator
	Rock Hill
	Carolina Cancer Specialists
		Steven A. Limentani	Ph: 704-355-2884
		Steven A. Limentani	Principal Investigator
	Seneca
	Cancer Centers of the Carolinas - Seneca
		Jeffrey K. Giguere	Ph: 864-241-6251
		Jeffrey K. Giguere	Principal Investigator
	Spartanburg
	Cancer Centers of the Carolinas - Spartanburg
		Jeffrey K. Giguere	Ph: 864-241-6251
		Jeffrey K. Giguere	Principal Investigator
	CCOP - Upstate Carolina
		Steven W. Corso	Ph: 800-486-5941
		Steven W. Corso	Principal Investigator
	Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
		Steven W. Corso	Ph: 800-486-5941
		Steven W. Corso	Principal Investigator
South Dakota
	Aberdeen
	Conklin Regional Cancer Center
		Richard J. Conklin	Ph: 605-622-5613
		Richard J. Conklin	Principal Investigator
	Rapid City
	Rapid City Regional Hospital
		Mark T. Schroeder	Ph: 605-716-3982
			Email: research@rcrh.org
		Mark T. Schroeder	Principal Investigator
	Sioux Falls
	Sanford Cancer Center at Sanford USD Medical Center
		Miroslaw A. Mazurczak	Ph: 605-328-1367
		Miroslaw A. Mazurczak	Principal Investigator
	Sanford USD Medical Center - Sioux Falls
		Miroslaw A. Mazurczak	Ph: 605-328-1367
		Miroslaw A. Mazurczak	Principal Investigator
Tennessee
	Bristol
	Blue Ridge Medical Specialists PC
		Asheesh Shipstone	Ph: 423-578-8538
		Asheesh Shipstone	Principal Investigator
	Wellmont Bristol Regional Medical Center
		Asheesh Shipstone	Ph: 423-578-8538
		Asheesh Shipstone	Principal Investigator
	Kingsport
	Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
		Asheesh Shipstone	Ph: 423-578-8538
		Asheesh Shipstone	Principal Investigator
	Knoxville
	Thompson Cancer Survival Center
		Daniel M. Ibach	Ph: 865-541-1812
		Daniel M. Ibach	Principal Investigator
	Nashville
	MBCCOP - Meharry Medical College - Nashville
		John J. Murray	Ph: 615-327-5724
			Email: jmurray@mmc.edu
		John J. Murray	Principal Investigator
Texas
	Abilene
	Hendrick Medical Center
		Jose A. Vega Dulanto	Ph: 888-823-5923
			Email: ctsucontact@westat.com
		Jose A. Vega Dulanto	Principal Investigator
	Amarillo
	Texas Oncology, PA - Amarillo
		Srini B. Reddy	Ph: 412-330-4624
			Email: Mary.ketner@nsabp.org
		Srini B. Reddy	Principal Investigator
	Austin
	University Medical Center Brackenridge
		Om N. Pandey	Ph: 512-324-7991
		Om N. Pandey	Principal Investigator
	Bedford
	Texas Oncology PA - Bedford
		Thomas C. Anderson	Ph: 817-685-4700
		Thomas C. Anderson	Principal Investigator
	Dallas
	Presbyterian Hospital of Dallas
		Kristi J. McIntyre	Ph: 214-345-8382
		Kristi J. McIntyre	Principal Investigator
	Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
		Barbara Jean B. Haley	Ph: 214-648-7097
		Barbara Jean B. Haley	Principal Investigator
	Texas Cancer Center - Medical City Dallas
		Michael A. Savin	Ph: 972-566-7790
		Michael A. Savin	Principal Investigator
	Denton
	Texas Oncology-Denton South
		Sharad K. Jain	Ph: 940-382-1022
		Sharad K. Jain	Principal Investigator
	El Paso
	Texas Oncology-El Paso
		Juan Herrada	Ph: 412-330-4624
			Email: Mary.ketner@nsabp.org
		Juan Herrada	Principal Investigator
	Flower Mound
	Texas Oncology-Flower Mound
		Derrick D. Nguyen	Ph: 972-537-4100
		Derrick D. Nguyen	Principal Investigator
	Fort Worth
	Texas Oncology Fort Worth at 12th Avenue
		Sanjay P. Oommen	Ph: 800-422-9567
		Sanjay P. Oommen	Principal Investigator
	Garland
	Texas Oncology - Garland
		Manish Gupta	Ph: 412-330-4624
			Email: Mary.ketner@nsabp.org
		Manish Gupta	Principal Investigator
	Houston
	Dan L. Duncan Cancer Center at Baylor College of Medicine
		Mothaffar F. Rimawi	Ph: 713-798-1354
			Email: burton@bcm.edu
		Mothaffar F. Rimawi	Principal Investigator
	Methodist Hospital
		Jenny Chee Ning Chang	Ph: 713-790-2700
			Email: burton@bcm.edu
		Jenny Chee Ning Chang	Principal Investigator
	Lewisville
	Texas Oncology, PA at Lake Vista Cancer Center
		Derrick D. Nguyen	Ph: 972-537-4100
		Derrick D. Nguyen	Principal Investigator
	McAllen
	Texas Oncology-McAllen
		Billiee J. Marek	Ph: 412-330-4624
			Email: Mary.ketner@nsabp.org
		Billiee J. Marek	Principal Investigator
	Plano
	North Texas Regional Cancer Center
		Christopher T. Stokoe	Ph: 412-330-4624
			Email: Mary.ketner@nsabp.org
		Christopher T. Stokoe	Principal Investigator
	Round Rock
	Texas Oncology, PA at Texas Cancer Center Round Rock
		Beth A. Hellerstedt	Ph: 512-341-8724
		Beth A. Hellerstedt	Principal Investigator
	San Antonio
	Cancer Care Centers of South Texas- Northeast
		Sharon T. Wilks	Ph: 210-656-7177
		Sharon T. Wilks	Principal Investigator
	Hematology Oncology Association of San Antonio Texas
		Alexander Zweibach	Ph: 210-595-5300
		Alexander Zweibach	Principal Investigator
	University of Texas Health Science Center at San Antonio
		Peter M. Ravdin	Ph: 210-616-5798
		Peter M. Ravdin	Principal Investigator
	Sherman
	Texas Oncology, PA at Texas Cancer Center - Sherman
		Tammy E. Roque	Ph: 903-868-4700
		Tammy E. Roque	Principal Investigator
	Temple
	Scott and White Cancer Institute
		Lucas Wong	Ph: 254-724-5407
		Lucas Wong	Principal Investigator
	The Woodlands
	US Oncology Research LLC-The Woodlands
		Christopher T. Stokoe	Ph: 412-330-4624
			Email: Mary.ketner@nsabp.org
		Christopher T. Stokoe	Principal Investigator
	Tyler
	Tyler Cancer Center
		Donald A. Richards	Ph: 903-579-9800
		Donald A. Richards	Principal Investigator
	Waco
	Texas Oncology PA
		Carlos A. Encarnacion	Ph: 412-330-4624
			Email: Mary.ketner@nsabp.org
		Carlos A. Encarnacion	Principal Investigator
	Wichita Falls
	Texas Oncology-Wichita Falls Texoma Cancer Center
		Brian K. Ulrich	Ph: 940-691-8271
		Brian K. Ulrich	Principal Investigator
Utah
	American Fork
	American Fork Hospital
		Carl R. Gray	Ph: 801-387-7426
		Carl R. Gray	Principal Investigator
	Cedar City
	Sandra L. Maxwell Cancer Center
		Carl R. Gray	Ph: 801-387-7426
		Carl R. Gray	Principal Investigator
	Logan
	Logan Regional Hospital
		Carl R. Gray	Ph: 801-387-7426
		Carl R. Gray	Principal Investigator
	Murray
	Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
		Carl R. Gray	Ph: 801-387-7426
		Carl R. Gray	Principal Investigator
	Ogden
	Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
		Carl R. Gray	Ph: 801-387-7426
		Carl R. Gray	Principal Investigator
	Provo
	Utah Valley Regional Medical Center
		Carl R. Gray	Ph: 801-387-7426
		Carl R. Gray	Principal Investigator
	Saint George
	Dixie Regional Medical Center - East Campus
		Carl R. Gray	Ph: 801-387-7426
		Carl R. Gray	Principal Investigator
	Salt Lake City
	LDS Hospital
		Carl R. Gray	Ph: 801-387-7426
		Carl R. Gray	Principal Investigator
	Utah Cancer Specialists at UCS Cancer Center
		Carl R. Gray	Ph: 801-387-7426
		Carl R. Gray	Principal Investigator
Vermont
	Berlin
	Mountainview Medical
		Kim L. Dittus	Ph: 802-656-8990
		Kim L. Dittus	Principal Investigator
	Burlington
	Vermont Cancer Center at University of Vermont
		Kim L. Dittus	Ph: 802-656-8990
		Kim L. Dittus	Principal Investigator
	Saint Johnsbury
	Norris Cotton Cancer Center-North
		Mary D. Chamberlin	Ph: 800-639-6918
			Email: cancer.research.nurse@dartmouth.edu
		Mary D. Chamberlin	Principal Investigator
Virginia
	Burke
	Kaiser Permanente-Burke Medical Center
		Leon C. Hwang	Ph: 301-816-7446
		Leon C. Hwang	Principal Investigator
	Charlottesville
	Martha Jefferson Hospital Cancer Care Center
		Robert S. Pritchard	Ph: 434-654-8400
		Robert S. Pritchard	Principal Investigator
	Danville
	Danville Regional Medical Center
		Timothy W. Brotherton	Ph: 434-793-0044
		Timothy W. Brotherton	Principal Investigator
	Fairfax
	Kaiser Permanente - Fair Oaks Medical Center
		Leon C. Hwang	Ph: 301-816-7446
		Leon C. Hwang	Principal Investigator
	Fredericksburg
	Fredericksburg Oncology, Incorporated
		Rex B. Mowat	Ph: 517-265-0116
		Rex B. Mowat	Principal Investigator
	Hematology-Oncology Associates of Fredericksburg, Incorporated
		Christopher N. Vaughn	Ph: 540-371-0079
		Christopher N. Vaughn	Principal Investigator
	Hampton
	Virginia Oncology Associates-Hampton
		John C. Paschold	Ph: 800-998-3450
		John C. Paschold	Principal Investigator
	Lynchburg
	Lynchburg Hematology-Oncology Clinic
		John L. MacNeill	Ph: 434-200-5925
		John L. MacNeill	Principal Investigator
	McLean
	Kaiser Permanente Tysons Corner Medical Center
		Leon C. Hwang	Ph: 301-816-7446
		Leon C. Hwang	Principal Investigator
	Newport News
	Peninsula Cancer Institute - Newport News Office
		Guy W. Tillinghast	Ph: 757-534-5565
			Email: oramae.jackson@rivhs.com
		Guy W. Tillinghast	Principal Investigator
	Norton
	Southwest Virginia Regional Cancer Center at Wellmonth Health
		Asheesh Shipstone	Ph: 423-578-8538
		Asheesh Shipstone	Principal Investigator
	Richmond
	Virginia Commonwealth University Massey Cancer Center
		Harry D. Bear	Ph: 804-628-1939
		Harry D. Bear	Principal Investigator
Washington
	Anacortes
	Cancer Care Center at Island Hospital
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Bellevue
	Overlake Cancer Center at Overlake Hospital Medical Center
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Bellingham
	PeaceHealth Saint Joseph Medical Center
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Bremerton
	Olympic Hematology and Oncology
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Burien
	Highline Medical Center-Main Campus
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Edmonds
	Puget Sound Cancer Centers - Edmonds
		J. Samuel Tolman	Ph: 206-368-1608
		J. Samuel Tolman	Principal Investigator
	Swedish Medical Center-Edmonds
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Issaquah
	Swedish Medical Center - Issaquah Campus
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Kennewick
	Columbia Basin Hematology
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Kirkland
	Cascade Cancer Center at Evergreen Hospital Medical Center
		Craig R. Nichols	Ph: 503-215-6412
		Craig R. Nichols	Principal Investigator
	Mount Vernon
	Skagit Valley Hospital
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Skagit Valley Hospital Cancer Care Center
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Poulsbo
	Harrison Poulsbo Hematology and Oncology
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Seattle
	CCOP - Virginia Mason Research Center
		Craig R. Nichols	Ph: 503-215-6412
		Craig R. Nichols	Principal Investigator
	Floyd and Delores Jones Cancer Institute at Virginia Mason Medical Center
		Craig R. Nichols	Ph: 503-215-6412
		Craig R. Nichols	Principal Investigator
	Fred Hutchinson Cancer Research Center
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Group Health Central Hospital
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Group Health Cooperative of Puget Sound Oncology Consortium
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Harborview Medical Center
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Minor and James Medical, PLLC
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Pacific Medical Center-First Hill
		Craig R. Nichols	Ph: 503-215-6412
		Craig R. Nichols	Principal Investigator
	Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	University Cancer Center at University of Washington Medical Center
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Sedro-Woolley
	North Puget Oncology at United General Hospital
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Sequim
	Olympic Medical Cancer Care Center
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Spokane
	Cancer Care Northwest - North
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Cancer Care Northwest - Spokane South
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Evergreen Hematology and Oncology, PS
		Gary E. Goodman	Ph: 206-386-2323
			Email: patra.grevstad@swedish.org
		Gary E. Goodman	Principal Investigator
	Rockwood Clinic Cancer Treatment Center
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Tacoma
	CCOP - Northwest
		Yoshio Inoue	Ph: 253-403-2394
		Yoshio Inoue	Principal Investigator
	Vancouver
	Legacy Salmon Creek Hospital
		Jay C. Andersen	Ph: 800-220-4937
		Jay C. Andersen	Principal Investigator
	Walla Walla
	Providence Saint Mary Regional Cancer Center
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Wenatchee
	Wenatchee Valley Medical Center
		Tanya A. Wahl	Ph: 425-688-5407
			Email: patra.grevstad@swedish.org
		Tanya A. Wahl	Principal Investigator
	Yakima
	North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
		Vicky E. Jones	Ph: 877-902-3324
		Vicky E. Jones	Principal Investigator
West Virginia
	Bridgeport
	United Hospital Center
		Paul M. Brager	Ph: 681-342-1000
		Paul M. Brager	Principal Investigator
	Charleston
	West Virginia University Health Sciences Center - Charleston
		Steven J. Jubelirer	Ph: 304-388-9944
		Steven J. Jubelirer	Principal Investigator
	Huntington
	Edwards Comprehensive Cancer Center at Cabell Huntington Hospital
		Maria R. Tria Tirona	Ph: 304-399-6617
		Maria R. Tria Tirona	Principal Investigator
	Saint Mary's Medical Center
		Arvinder S. Bir	Ph: 888-823-5923
			Email: ctsucontact@westat.com
		Arvinder S. Bir	Principal Investigator
	Morgantown
	Mary Babb Randolph Cancer Center at West Virginia University Hospitals
		Jame Abraham	Ph: 304-293-2745
			Email: sfilburn@hsc.wvu.edu
		Jame Abraham	Principal Investigator
	Princeton
	Princeton Community Hospital
		Rowena Gonzales-Chambers	Ph: 304-487-7000
		Rowena Gonzales-Chambers	Principal Investigator
Wisconsin
	Antigo
	Langlade Memorial Hospital
		Hamied R. Rezazadeh	Ph: 877-405-6866
		Hamied R. Rezazadeh	Principal Investigator
	Appleton
	Fox Valley Hematology and Oncology - East Grant Street
		Avi Bar-Lev	Ph: 920-749-1171
		Avi Bar-Lev	Principal Investigator
	Chippewa Falls
	Marshfield Clinic-Chippewa Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Eau Claire
	Center for Cancer Treatment & Prevention at Sacred Heart Hospital
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Marshfield Clinic Cancer Care at Regional Cancer Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Fond Du Lac
	Central Wisconsin Cancer Program at Agnesian HealthCare
		Sayeh M. Lavasani	Ph: 313-576-9363
		Sayeh M. Lavasani	Principal Investigator
	Green Bay
	Green Bay Oncology, Limited at St. Mary's Hospital
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	St. Mary's Hospital Medical Center - Green Bay
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	St. Vincent Hospital Regional Cancer Center
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	Vince Lombardi Cancer Clinic - Green Bay at Aurora BayCare Medical Center
		Dhimant R. Patel	Ph: 800-252-2990
		Dhimant R. Patel	Principal Investigator
	Janesville
	Mercy Regional Cancer Center
		Emily G. Robinson	Ph: 800-928-1103
		Emily G. Robinson	Principal Investigator
	Johnson Creek
	UW Cancer Center Johnson Creek
		Uchenna O. Njiaju	Ph: 773-834-7424
		Uchenna O. Njiaju	Principal Investigator
	La Crosse
	Gundersen Lutheran Center for Cancer and Blood
		Kurt Oettel	Ph: 608-775-2385
			Email: cancerctr@gundluth.org
		Kurt Oettel	Principal Investigator
	Madison
	Dean Hematology & Oncology Clinic
		Amit Sanyal	Ph: 608-410-2700
		Amit Sanyal	Principal Investigator
	University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
		Uchenna O. Njiaju	Ph: 773-834-7424
		Uchenna O. Njiaju	Principal Investigator
	Manitowoc
	Holy Family Memorial Medical Center Cancer Care Center
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	Marinette
	Bay Area Cancer Care Center at Bay Area Medical Center
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	Vince Lombardi Cancer Clinic - Marinette
		Dhimant R. Patel	Ph: 800-252-2990
		Dhimant R. Patel	Principal Investigator
	Marshfield
	Marshfield Clinic - Marshfield Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Saint Joseph's Hospital
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Mequon
	Columbia Saint Mary's Hospital - Ozaukee
		Charles H. Tiber	Ph: 414-326-2675
			Email: clinicaltrials@columbia-stmarys.org
		Charles H. Tiber	Principal Investigator
	Milwaukee
	Columbia-Saint Mary's Cancer Care Center
		Charles H. Tiber	Ph: 414-326-2675
			Email: clinicaltrials@columbia-stmarys.org
		Charles H. Tiber	Principal Investigator
	Wheaton Franciscan Healthcare - Saint Joseph
		Francis J. Cuevas	Ph: 414-874-4541
		Francis J. Cuevas	Principal Investigator
	Minocqua
	Marshfield Clinic - Lakeland Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Mukwonago
	D.N. Greenwald Center
		Michael A. Thompson	Ph: 262-928-7632
		Michael A. Thompson	Principal Investigator
	New Richmond
	Cancer Center of Western Wisconsin
		Joseph W. Leach	Ph: 952-993-1517
			Email: MMCCOP@parknicollet.com
		Joseph W. Leach	Principal Investigator
	Oconomowoc
	Regional Cancer Center at Oconomowoc Memorial Hospital
		Michael A. Thompson	Ph: 262-928-7632
		Michael A. Thompson	Principal Investigator
	Oconto Falls
	Green Bay Oncology, Limited - Oconto Falls
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	Oshkosh
	Vince Lombardi Cancer Clinic - Oshkosh
		Dhimant R. Patel	Ph: 800-252-2990
		Dhimant R. Patel	Principal Investigator
	Racine
	Wheaton Franciscan Cancer Care - All Saints
		Young M. Choi	Ph: 414-874-4541
			Email: Kelli.holton@wfhc.org
		Young M. Choi	Principal Investigator
	Rhinelander
	Ministry Medical Group at Saint Mary's Hospital
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Saint Mary's Hospital
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Rice Lake
	Marshfield Clinic - Indianhead Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Sheboygan
	Saint Nicholas Hospital
		Pamela Vanderwall	Ph: 920-433-8889
		Pamela Vanderwall	Principal Investigator
	Vince Lombardi Cancer Clinic-Sheboygan
		Dhimant R. Patel	Ph: 800-252-2990
		Dhimant R. Patel	Principal Investigator
	Stevens Point
	Marshfield Clinic Cancer Care at Saint Michael's Hospital
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Saint Michael's Hospital Cancer Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Sturgeon Bay
	Green Bay Oncology, Limited - Sturgeon Bay
		Matthew L. Ryan	Ph: 800-432-6049
		Matthew L. Ryan	Principal Investigator
	Summit
	Aurora Medical Center in Summit
		Dhimant R. Patel	Ph: 800-252-2990
		Dhimant R. Patel	Principal Investigator
	Two Rivers
	Vince Lombardi Cancer Clinic
		Dhimant R. Patel	Ph: 800-252-2990
		Dhimant R. Patel	Principal Investigator
	Waukesha
	Waukesha Memorial Hospital Regional Cancer Center
		Michael A. Thompson	Ph: 262-928-7632
		Michael A. Thompson	Principal Investigator
	Wausau
	Marshfield Clinic - Wausau Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	University of Wisconcin Cancer Center at Aspirus Wausau Hospital
		Hamied R. Rezazadeh	Ph: 877-405-6866
		Hamied R. Rezazadeh	Principal Investigator
	Weston
	Diagnostic and Treatment Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Marshfield Clinic - Weston Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Ministry Saint Clare's Hospital
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
	Wisconsin Rapids
	Marshfield Clinic - Wisconsin Rapids Center
		Jessica A. Wernberg	Ph: 715-389-4457
		Jessica A. Wernberg	Principal Investigator
Wyoming
	Casper
	Rocky Mountain Oncology
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
	Sheridan
	Welch Cancer Center at Sheridan Memorial Hospital
		Benjamin T. Marchello	Ph: 800-648-6274
		Benjamin T. Marchello	Principal Investigator
Canada
Alberta
	Calgary
	Tom Baker Cancer Centre - Calgary
		Alexander H. Paterson	Ph: 403-521-3433
		Alexander H. Paterson	Principal Investigator
Quebec
	Montreal
	CHUM-Hotel Dieu du Montreal
		Andre Robidoux	Ph: 514-890-8000ext14788
			Email: marie-josee.samson.chum@ssss.gouv.qc.ca
		Andre Robidoux	Principal Investigator
	Hopital Notre-Dame du CHUM
		Andre Robidoux	Ph: 514-890-8000ext14788
			Email: marie-josee.samson.chum@ssss.gouv.qc.ca
		Andre Robidoux	Principal Investigator
	Jewish General Hospital - Montreal
		Richard G. Margolese	Ph: 514-340-8222ext8248
		Richard G. Margolese	Principal Investigator
	Montreal General Hospital
		Michael P. Thirlwell	Ph: 514-934-1934ext42953
			Email: evelyn.ortega@muhc.mcgill.ca
		Michael P. Thirlwell	Principal Investigator
	Saint Mary's Hospital
		Jaroslav F. Prchal	Ph: 514-345-3511ext5060
			Email: shantel.brown.chsm@ssss.gouv.qc.ca
		Jaroslav F. Prchal	Principal Investigator
	Quebec City
	Le Centre hospitalier affilie universitaire de Quebec-Saint Sacrement
		Louise Provencher	Ph: 418-649-5593
			Email: jbegin@uresp.ulaval.ca
		Louise Provencher	Principal Investigator
Ireland
	Cork
	Cork University Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Dublin
	St. James's Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Galway
	Galway University Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Letterkenny
	Letterkenny General Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Limerick
	Mid-Western Regional Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Sligo
	Sligo General Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Waterford
	http://www.hse.ie/eng/services/Find_a_Service/National_Cancer_Control_Programme/
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
Cork
	Cork
	Bon Secours Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
Dublin
	Dublin
	Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Beaumont Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Mater Misericordiae University Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Mater Private Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Saint Vincents Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator
	Merrion
	Saint Vincent's Private Hospital
		John A. Crown	Ph: 353 1 2638380
		John A. Crown	Principal Investigator